A549 cells infected with SARS-CoV-2 Analysis Results (GEO series: GSE147507)
Gene Symbol | Gene ID | Gene Info |
---|---|---|
SMAD4
|
ENSG00000141646.9 | SMAD family member 4 |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
SMAD4 | hg19_v2_chr18_+_48494361_48494426 | -0.80 | 5.5e-02 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr22_+_30752606 | 2.12 |
ENST00000399824.2
ENST00000405659.1 ENST00000338306.3 |
CCDC157
|
coiled-coil domain containing 157 |
chr1_-_32827682 | 1.96 |
ENST00000432622.1
|
FAM229A
|
family with sequence similarity 229, member A |
chr11_+_117070037 | 1.72 |
ENST00000392951.4
ENST00000525531.1 ENST00000278968.6 |
TAGLN
|
transgelin |
chr12_+_48147699 | 1.55 |
ENST00000548498.1
|
SLC48A1
|
solute carrier family 48 (heme transporter), member 1 |
chr5_-_151066514 | 1.54 |
ENST00000538026.1
ENST00000522348.1 ENST00000521569.1 |
SPARC
|
secreted protein, acidic, cysteine-rich (osteonectin) |
chr6_-_31651817 | 1.53 |
ENST00000375863.3
ENST00000375860.2 |
LY6G5C
|
lymphocyte antigen 6 complex, locus G5C |
chr12_-_53207842 | 1.29 |
ENST00000458244.2
|
KRT4
|
keratin 4 |
chr9_+_140119618 | 1.22 |
ENST00000359069.2
|
C9orf169
|
chromosome 9 open reading frame 169 |
chr19_-_49522727 | 1.21 |
ENST00000600007.1
|
CTB-60B18.10
|
CTB-60B18.10 |
chr11_+_115498761 | 1.20 |
ENST00000424313.2
|
AP000997.1
|
AP000997.1 |
chr5_+_127039075 | 1.17 |
ENST00000514853.2
|
CTC-228N24.1
|
CTC-228N24.1 |
chr19_+_10527449 | 1.12 |
ENST00000592685.1
ENST00000380702.2 |
PDE4A
|
phosphodiesterase 4A, cAMP-specific |
chr6_+_116937636 | 1.09 |
ENST00000368581.4
ENST00000229554.5 ENST00000368580.4 |
RSPH4A
|
radial spoke head 4 homolog A (Chlamydomonas) |
chr22_+_22676808 | 1.09 |
ENST00000390290.2
|
IGLV1-51
|
immunoglobulin lambda variable 1-51 |
chr1_+_228645796 | 1.08 |
ENST00000369160.2
|
HIST3H2BB
|
histone cluster 3, H2bb |
chr8_-_37594944 | 1.06 |
ENST00000330539.1
|
RP11-863K10.7
|
Uncharacterized protein |
chr22_-_26875345 | 1.04 |
ENST00000398141.1
|
HPS4
|
Hermansky-Pudlak syndrome 4 |
chr11_+_62475130 | 1.04 |
ENST00000294117.5
|
GNG3
|
guanine nucleotide binding protein (G protein), gamma 3 |
chr2_-_228028829 | 1.02 |
ENST00000396625.3
ENST00000329662.7 |
COL4A4
|
collagen, type IV, alpha 4 |
chr1_-_207095324 | 0.98 |
ENST00000530505.1
ENST00000367091.3 ENST00000442471.2 |
FAIM3
|
Fas apoptotic inhibitory molecule 3 |
chr19_+_49617581 | 0.97 |
ENST00000391864.3
|
LIN7B
|
lin-7 homolog B (C. elegans) |
chr8_-_73793975 | 0.97 |
ENST00000523881.1
|
RP11-1145L24.1
|
RP11-1145L24.1 |
chr22_-_30234218 | 0.96 |
ENST00000307790.3
ENST00000542393.1 ENST00000397771.2 |
ASCC2
|
activating signal cointegrator 1 complex subunit 2 |
chr4_-_185776854 | 0.96 |
ENST00000511703.1
|
RP11-701P16.5
|
RP11-701P16.5 |
chr6_-_31938700 | 0.93 |
ENST00000495340.1
|
DXO
|
decapping exoribonuclease |
chr19_-_47734448 | 0.93 |
ENST00000439096.2
|
BBC3
|
BCL2 binding component 3 |
chr19_+_507299 | 0.93 |
ENST00000359315.5
|
TPGS1
|
tubulin polyglutamylase complex subunit 1 |
chr21_-_44751903 | 0.91 |
ENST00000450205.1
|
LINC00322
|
long intergenic non-protein coding RNA 322 |
chr15_-_82338460 | 0.90 |
ENST00000558133.1
ENST00000329713.4 |
MEX3B
|
mex-3 RNA binding family member B |
chr1_+_32827759 | 0.87 |
ENST00000373534.3
|
TSSK3
|
testis-specific serine kinase 3 |
chr7_-_55620433 | 0.87 |
ENST00000418904.1
|
VOPP1
|
vesicular, overexpressed in cancer, prosurvival protein 1 |
chr1_+_110162448 | 0.87 |
ENST00000342115.4
ENST00000469039.2 ENST00000474459.1 ENST00000528667.1 |
AMPD2
|
adenosine monophosphate deaminase 2 |
chr16_-_28550348 | 0.83 |
ENST00000324873.6
|
NUPR1
|
nuclear protein, transcriptional regulator, 1 |
chr11_+_46366918 | 0.79 |
ENST00000528615.1
ENST00000395574.3 |
DGKZ
|
diacylglycerol kinase, zeta |
chr4_+_183370146 | 0.79 |
ENST00000510504.1
|
TENM3
|
teneurin transmembrane protein 3 |
chr1_+_95975672 | 0.79 |
ENST00000440116.2
ENST00000456933.1 |
RP11-286B14.1
|
RP11-286B14.1 |
chr2_+_242752474 | 0.78 |
ENST00000435934.1
ENST00000435894.1 ENST00000426032.1 ENST00000420288.1 |
NEU4
|
sialidase 4 |
chr10_+_81892477 | 0.77 |
ENST00000372263.3
|
PLAC9
|
placenta-specific 9 |
chr17_+_73539232 | 0.77 |
ENST00000580925.1
|
LLGL2
|
lethal giant larvae homolog 2 (Drosophila) |
chr20_+_60174827 | 0.77 |
ENST00000543233.1
|
CDH4
|
cadherin 4, type 1, R-cadherin (retinal) |
chr3_-_195619579 | 0.76 |
ENST00000428187.1
|
TNK2
|
tyrosine kinase, non-receptor, 2 |
chr3_-_112127981 | 0.76 |
ENST00000486726.2
|
RP11-231E6.1
|
RP11-231E6.1 |
chr7_-_27219632 | 0.76 |
ENST00000470747.4
|
RP1-170O19.20
|
Uncharacterized protein |
chr17_-_3495644 | 0.75 |
ENST00000310522.5
ENST00000425167.2 ENST00000576351.1 |
TRPV1
|
transient receptor potential cation channel, subfamily V, member 1 |
chr22_+_31199037 | 0.75 |
ENST00000424224.1
|
OSBP2
|
oxysterol binding protein 2 |
chr1_-_183538319 | 0.74 |
ENST00000420553.1
ENST00000419402.1 |
NCF2
|
neutrophil cytosolic factor 2 |
chr12_+_52450298 | 0.74 |
ENST00000550582.2
|
NR4A1
|
nuclear receptor subfamily 4, group A, member 1 |
chr14_-_95942173 | 0.74 |
ENST00000334258.5
ENST00000557275.1 ENST00000553340.1 |
SYNE3
|
spectrin repeat containing, nuclear envelope family member 3 |
chr7_-_27219849 | 0.74 |
ENST00000396344.4
|
HOXA10
|
homeobox A10 |
chr20_+_816695 | 0.73 |
ENST00000246100.3
|
FAM110A
|
family with sequence similarity 110, member A |
chr1_+_202385953 | 0.72 |
ENST00000466968.1
|
PPP1R12B
|
protein phosphatase 1, regulatory subunit 12B |
chr19_-_43709772 | 0.72 |
ENST00000596907.1
ENST00000451895.1 |
PSG4
|
pregnancy specific beta-1-glycoprotein 4 |
chr17_+_39405939 | 0.72 |
ENST00000334109.2
|
KRTAP9-4
|
keratin associated protein 9-4 |
chr6_-_53013620 | 0.71 |
ENST00000259803.7
|
GCM1
|
glial cells missing homolog 1 (Drosophila) |
chr6_-_27100529 | 0.71 |
ENST00000607124.1
ENST00000339812.2 ENST00000541790.1 |
HIST1H2BJ
|
histone cluster 1, H2bj |
chr14_+_69726656 | 0.71 |
ENST00000337827.4
|
GALNT16
|
UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 16 |
chr17_-_7297519 | 0.70 |
ENST00000576362.1
ENST00000571078.1 |
TMEM256-PLSCR3
|
TMEM256-PLSCR3 readthrough (NMD candidate) |
chr7_+_134551583 | 0.70 |
ENST00000435928.1
|
CALD1
|
caldesmon 1 |
chr1_+_223889310 | 0.70 |
ENST00000434648.1
|
CAPN2
|
calpain 2, (m/II) large subunit |
chr4_+_40337340 | 0.69 |
ENST00000310169.2
|
CHRNA9
|
cholinergic receptor, nicotinic, alpha 9 (neuronal) |
chr19_-_46105411 | 0.69 |
ENST00000323040.4
ENST00000544371.1 |
GPR4
OPA3
|
G protein-coupled receptor 4 optic atrophy 3 (autosomal recessive, with chorea and spastic paraplegia) |
chr19_+_48898132 | 0.69 |
ENST00000263269.3
|
GRIN2D
|
glutamate receptor, ionotropic, N-methyl D-aspartate 2D |
chr12_-_57634475 | 0.68 |
ENST00000393825.1
|
NDUFA4L2
|
NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 4-like 2 |
chr22_+_20877924 | 0.68 |
ENST00000445189.1
|
MED15
|
mediator complex subunit 15 |
chr22_-_45608237 | 0.67 |
ENST00000492273.1
|
KIAA0930
|
KIAA0930 |
chr15_+_67420441 | 0.67 |
ENST00000558894.1
|
SMAD3
|
SMAD family member 3 |
chr11_-_96239990 | 0.67 |
ENST00000511243.2
|
JRKL-AS1
|
JRKL antisense RNA 1 |
chr16_-_31076332 | 0.66 |
ENST00000539836.3
ENST00000535577.1 ENST00000442862.2 |
ZNF668
|
zinc finger protein 668 |
chr16_-_31076273 | 0.66 |
ENST00000426488.2
|
ZNF668
|
zinc finger protein 668 |
chr3_+_187086120 | 0.66 |
ENST00000259030.2
|
RTP4
|
receptor (chemosensory) transporter protein 4 |
chr2_+_102618428 | 0.66 |
ENST00000457817.1
|
IL1R2
|
interleukin 1 receptor, type II |
chr15_-_40633101 | 0.65 |
ENST00000559313.1
|
C15orf52
|
chromosome 15 open reading frame 52 |
chr5_+_156696362 | 0.64 |
ENST00000377576.3
|
CYFIP2
|
cytoplasmic FMR1 interacting protein 2 |
chr3_-_52869205 | 0.63 |
ENST00000446157.2
|
MUSTN1
|
musculoskeletal, embryonic nuclear protein 1 |
chrX_-_30327495 | 0.63 |
ENST00000453287.1
|
NR0B1
|
nuclear receptor subfamily 0, group B, member 1 |
chr11_+_46366799 | 0.62 |
ENST00000532868.2
|
DGKZ
|
diacylglycerol kinase, zeta |
chr7_+_114562616 | 0.62 |
ENST00000448022.1
|
MDFIC
|
MyoD family inhibitor domain containing |
chr7_-_150777920 | 0.62 |
ENST00000353841.2
ENST00000297532.6 |
FASTK
|
Fas-activated serine/threonine kinase |
chr22_+_22988816 | 0.62 |
ENST00000480559.1
ENST00000448514.1 |
GGTLC2
|
gamma-glutamyltransferase light chain 2 |
chr18_+_3449330 | 0.62 |
ENST00000549253.1
|
TGIF1
|
TGFB-induced factor homeobox 1 |
chr7_-_150777949 | 0.61 |
ENST00000482571.1
|
FASTK
|
Fas-activated serine/threonine kinase |
chr17_-_73874654 | 0.61 |
ENST00000254816.2
|
TRIM47
|
tripartite motif containing 47 |
chr15_-_102285007 | 0.61 |
ENST00000560292.2
|
RP11-89K11.1
|
Uncharacterized protein |
chr17_-_20370847 | 0.61 |
ENST00000423676.3
ENST00000324290.5 |
LGALS9B
|
lectin, galactoside-binding, soluble, 9B |
chr3_+_50654821 | 0.60 |
ENST00000457064.1
|
MAPKAPK3
|
mitogen-activated protein kinase-activated protein kinase 3 |
chr22_+_27068704 | 0.60 |
ENST00000444388.1
ENST00000450963.1 ENST00000449017.1 |
CTA-211A9.5
|
CTA-211A9.5 |
chr8_-_130587237 | 0.60 |
ENST00000520048.1
|
CCDC26
|
coiled-coil domain containing 26 |
chr22_+_40573921 | 0.60 |
ENST00000454349.2
ENST00000335727.9 |
TNRC6B
|
trinucleotide repeat containing 6B |
chr19_+_17516531 | 0.60 |
ENST00000528911.1
ENST00000528604.1 ENST00000595892.1 ENST00000500836.2 ENST00000598546.1 ENST00000600369.1 ENST00000598356.1 ENST00000594426.1 |
MVB12A
CTD-2521M24.9
|
multivesicular body subunit 12A CTD-2521M24.9 |
chr6_+_43738444 | 0.60 |
ENST00000324450.6
ENST00000417285.2 ENST00000413642.3 ENST00000372055.4 ENST00000482630.2 ENST00000425836.2 ENST00000372064.4 ENST00000372077.4 ENST00000519767.1 |
VEGFA
|
vascular endothelial growth factor A |
chr19_-_49568311 | 0.59 |
ENST00000595857.1
ENST00000451356.2 |
NTF4
|
neurotrophin 4 |
chr11_-_61596753 | 0.59 |
ENST00000448607.1
ENST00000421879.1 |
FADS1
|
fatty acid desaturase 1 |
chr2_+_30454390 | 0.59 |
ENST00000395323.3
ENST00000406087.1 ENST00000404397.1 |
LBH
|
limb bud and heart development |
chr19_+_50094866 | 0.59 |
ENST00000418929.2
|
PRR12
|
proline rich 12 |
chr19_+_51728316 | 0.58 |
ENST00000436584.2
ENST00000421133.2 ENST00000391796.3 ENST00000262262.4 |
CD33
|
CD33 molecule |
chr2_+_220306238 | 0.58 |
ENST00000435853.1
|
SPEG
|
SPEG complex locus |
chr1_+_27668505 | 0.58 |
ENST00000318074.5
|
SYTL1
|
synaptotagmin-like 1 |
chr12_-_106477805 | 0.58 |
ENST00000553094.1
ENST00000549704.1 |
NUAK1
|
NUAK family, SNF1-like kinase, 1 |
chr1_+_6684918 | 0.58 |
ENST00000054650.4
|
THAP3
|
THAP domain containing, apoptosis associated protein 3 |
chr9_-_140513231 | 0.57 |
ENST00000371417.3
|
C9orf37
|
chromosome 9 open reading frame 37 |
chr19_-_4338783 | 0.57 |
ENST00000601482.1
ENST00000600324.1 |
STAP2
|
signal transducing adaptor family member 2 |
chr1_+_89829610 | 0.57 |
ENST00000370456.4
ENST00000535065.1 |
GBP6
|
guanylate binding protein family, member 6 |
chr9_-_139891165 | 0.56 |
ENST00000494426.1
|
CLIC3
|
chloride intracellular channel 3 |
chr6_-_37665751 | 0.56 |
ENST00000297153.7
ENST00000434837.3 |
MDGA1
|
MAM domain containing glycosylphosphatidylinositol anchor 1 |
chr11_-_17410629 | 0.56 |
ENST00000526912.1
|
KCNJ11
|
potassium inwardly-rectifying channel, subfamily J, member 11 |
chr1_+_236557569 | 0.56 |
ENST00000334232.4
|
EDARADD
|
EDAR-associated death domain |
chr1_-_156460391 | 0.56 |
ENST00000360595.3
|
MEF2D
|
myocyte enhancer factor 2D |
chr1_+_1334914 | 0.56 |
ENST00000576232.1
ENST00000570344.1 |
RP4-758J18.2
|
HCG20425, isoform CRA_a; Uncharacterized protein; cDNA FLJ53815 |
chr3_+_184016986 | 0.56 |
ENST00000417952.1
|
PSMD2
|
proteasome (prosome, macropain) 26S subunit, non-ATPase, 2 |
chr22_-_43567750 | 0.56 |
ENST00000494035.1
|
TTLL12
|
tubulin tyrosine ligase-like family, member 12 |
chr22_+_30752963 | 0.56 |
ENST00000445005.1
ENST00000430839.1 |
CCDC157
|
coiled-coil domain containing 157 |
chr16_+_29840929 | 0.56 |
ENST00000566252.1
|
MVP
|
major vault protein |
chr8_-_28965684 | 0.56 |
ENST00000523130.1
|
KIF13B
|
kinesin family member 13B |
chr14_+_64680854 | 0.55 |
ENST00000458046.2
|
SYNE2
|
spectrin repeat containing, nuclear envelope 2 |
chr7_-_155601766 | 0.55 |
ENST00000430104.1
|
SHH
|
sonic hedgehog |
chr16_-_66959429 | 0.55 |
ENST00000420652.1
ENST00000299759.6 |
RRAD
|
Ras-related associated with diabetes |
chr6_+_168434678 | 0.55 |
ENST00000496008.1
|
KIF25
|
kinesin family member 25 |
chr9_-_130616915 | 0.55 |
ENST00000344849.3
|
ENG
|
endoglin |
chr19_-_40324767 | 0.55 |
ENST00000601972.1
ENST00000430012.2 ENST00000323039.5 ENST00000348817.3 |
DYRK1B
|
dual-specificity tyrosine-(Y)-phosphorylation regulated kinase 1B |
chr16_+_68279207 | 0.54 |
ENST00000413021.2
ENST00000565744.1 ENST00000219345.5 |
PLA2G15
|
phospholipase A2, group XV |
chrX_+_153029633 | 0.54 |
ENST00000538966.1
ENST00000361971.5 ENST00000538776.1 ENST00000538543.1 |
PLXNB3
|
plexin B3 |
chr22_-_20368028 | 0.54 |
ENST00000404912.1
|
GGTLC3
|
gamma-glutamyltransferase light chain 3 |
chr5_+_148521454 | 0.54 |
ENST00000508983.1
|
ABLIM3
|
actin binding LIM protein family, member 3 |
chr3_-_8686479 | 0.54 |
ENST00000544814.1
ENST00000427408.1 |
SSUH2
|
ssu-2 homolog (C. elegans) |
chr18_+_20714525 | 0.54 |
ENST00000400473.2
|
CABLES1
|
Cdk5 and Abl enzyme substrate 1 |
chr1_+_42619070 | 0.53 |
ENST00000372581.1
|
GUCA2B
|
guanylate cyclase activator 2B (uroguanylin) |
chr2_+_239756671 | 0.53 |
ENST00000448943.2
|
TWIST2
|
twist family bHLH transcription factor 2 |
chr1_+_201592013 | 0.53 |
ENST00000593583.1
|
AC096677.1
|
Uncharacterized protein ENSP00000471857 |
chr2_+_227771404 | 0.53 |
ENST00000409053.1
|
RHBDD1
|
rhomboid domain containing 1 |
chr17_-_33448468 | 0.53 |
ENST00000591723.1
ENST00000593039.1 ENST00000587405.1 |
RAD51L3-RFFL
RAD51D
|
Uncharacterized protein RAD51 paralog D |
chr20_-_56265680 | 0.53 |
ENST00000414037.1
|
PMEPA1
|
prostate transmembrane protein, androgen induced 1 |
chr8_-_145028013 | 0.52 |
ENST00000354958.2
|
PLEC
|
plectin |
chr11_-_8739383 | 0.52 |
ENST00000531060.1
|
ST5
|
suppression of tumorigenicity 5 |
chr5_+_148521046 | 0.52 |
ENST00000326685.7
ENST00000356541.3 ENST00000309868.7 |
ABLIM3
|
actin binding LIM protein family, member 3 |
chr14_-_81893734 | 0.52 |
ENST00000555447.1
|
STON2
|
stonin 2 |
chr17_+_72211755 | 0.52 |
ENST00000529107.1
|
TTYH2
|
tweety family member 2 |
chr2_+_113479063 | 0.51 |
ENST00000327581.4
|
NT5DC4
|
5'-nucleotidase domain containing 4 |
chr22_+_31644388 | 0.51 |
ENST00000333611.4
ENST00000340552.4 |
LIMK2
|
LIM domain kinase 2 |
chr12_+_122242597 | 0.51 |
ENST00000267197.5
|
SETD1B
|
SET domain containing 1B |
chr1_+_179050512 | 0.51 |
ENST00000367627.3
|
TOR3A
|
torsin family 3, member A |
chr16_+_23690138 | 0.51 |
ENST00000300093.4
|
PLK1
|
polo-like kinase 1 |
chr19_+_42788172 | 0.51 |
ENST00000160740.3
|
CIC
|
capicua transcriptional repressor |
chr5_-_111093081 | 0.51 |
ENST00000453526.2
ENST00000509427.1 |
NREP
|
neuronal regeneration related protein |
chr2_+_232575168 | 0.51 |
ENST00000440384.1
|
PTMA
|
prothymosin, alpha |
chr22_+_31003133 | 0.51 |
ENST00000405742.3
|
TCN2
|
transcobalamin II |
chr1_+_212782012 | 0.51 |
ENST00000341491.4
ENST00000366985.1 |
ATF3
|
activating transcription factor 3 |
chr20_+_1875110 | 0.51 |
ENST00000400068.3
|
SIRPA
|
signal-regulatory protein alpha |
chr3_-_39149082 | 0.51 |
ENST00000427459.1
ENST00000411813.1 ENST00000422110.2 ENST00000479927.1 |
GORASP1
|
golgi reassembly stacking protein 1, 65kDa |
chr2_+_30455016 | 0.51 |
ENST00000401506.1
ENST00000407930.2 |
LBH
|
limb bud and heart development |
chr2_-_70780572 | 0.50 |
ENST00000450929.1
|
TGFA
|
transforming growth factor, alpha |
chr3_+_171844762 | 0.50 |
ENST00000443501.1
|
FNDC3B
|
fibronectin type III domain containing 3B |
chr19_-_47231216 | 0.50 |
ENST00000594287.2
|
STRN4
|
striatin, calmodulin binding protein 4 |
chr17_+_74536115 | 0.50 |
ENST00000592014.1
|
PRCD
|
progressive rod-cone degeneration |
chrX_-_53711064 | 0.49 |
ENST00000342160.3
ENST00000446750.1 |
HUWE1
|
HECT, UBA and WWE domain containing 1, E3 ubiquitin protein ligase |
chr3_-_120365866 | 0.49 |
ENST00000475447.2
|
HGD
|
homogentisate 1,2-dioxygenase |
chr12_-_49365501 | 0.49 |
ENST00000403957.1
ENST00000301061.4 |
WNT10B
|
wingless-type MMTV integration site family, member 10B |
chr19_+_9203855 | 0.49 |
ENST00000429566.3
|
OR1M1
|
olfactory receptor, family 1, subfamily M, member 1 |
chr11_-_67276100 | 0.48 |
ENST00000301488.3
|
CDK2AP2
|
cyclin-dependent kinase 2 associated protein 2 |
chr1_+_39796810 | 0.48 |
ENST00000289893.4
|
MACF1
|
microtubule-actin crosslinking factor 1 |
chr5_+_140071178 | 0.48 |
ENST00000508522.1
ENST00000448069.2 |
HARS2
|
histidyl-tRNA synthetase 2, mitochondrial |
chr16_-_29499154 | 0.48 |
ENST00000354563.5
|
RP11-231C14.4
|
Uncharacterized protein |
chr9_-_130617029 | 0.48 |
ENST00000373203.4
|
ENG
|
endoglin |
chr17_-_7297833 | 0.48 |
ENST00000571802.1
ENST00000576201.1 ENST00000573213.1 ENST00000324822.11 |
TMEM256-PLSCR3
|
TMEM256-PLSCR3 readthrough (NMD candidate) |
chr12_-_70093235 | 0.48 |
ENST00000266661.4
|
BEST3
|
bestrophin 3 |
chr2_-_220252068 | 0.48 |
ENST00000430206.1
ENST00000429013.1 |
DNPEP
|
aspartyl aminopeptidase |
chr19_+_41281060 | 0.48 |
ENST00000594436.1
ENST00000597784.1 |
MIA
|
melanoma inhibitory activity |
chr22_-_37823468 | 0.47 |
ENST00000402918.2
|
ELFN2
|
extracellular leucine-rich repeat and fibronectin type III domain containing 2 |
chr19_-_47287990 | 0.47 |
ENST00000593713.1
ENST00000598022.1 ENST00000434726.2 |
SLC1A5
|
solute carrier family 1 (neutral amino acid transporter), member 5 |
chr1_+_6051526 | 0.47 |
ENST00000378111.1
|
KCNAB2
|
potassium voltage-gated channel, shaker-related subfamily, beta member 2 |
chr8_+_118532937 | 0.47 |
ENST00000297347.3
|
MED30
|
mediator complex subunit 30 |
chr16_+_3070356 | 0.47 |
ENST00000341627.5
ENST00000575124.1 ENST00000575836.1 |
TNFRSF12A
|
tumor necrosis factor receptor superfamily, member 12A |
chr3_+_9958758 | 0.46 |
ENST00000383812.4
ENST00000438091.1 ENST00000295981.3 ENST00000436503.1 ENST00000403601.3 ENST00000416074.2 ENST00000455057.1 |
IL17RC
|
interleukin 17 receptor C |
chr15_-_44069513 | 0.46 |
ENST00000433927.1
|
ELL3
|
elongation factor RNA polymerase II-like 3 |
chr16_-_21436459 | 0.46 |
ENST00000448012.2
ENST00000504841.2 ENST00000419180.2 |
NPIPB3
|
nuclear pore complex interacting protein family, member B3 |
chr4_+_169418255 | 0.46 |
ENST00000505667.1
ENST00000511948.1 |
PALLD
|
palladin, cytoskeletal associated protein |
chr22_-_21579843 | 0.46 |
ENST00000405188.4
|
GGT2
|
gamma-glutamyltransferase 2 |
chr16_-_29517141 | 0.46 |
ENST00000550665.1
|
RP11-231C14.4
|
Uncharacterized protein |
chr1_-_159832438 | 0.46 |
ENST00000368100.1
|
VSIG8
|
V-set and immunoglobulin domain containing 8 |
chrX_-_48815633 | 0.46 |
ENST00000428668.2
|
OTUD5
|
OTU domain containing 5 |
chr22_+_31002990 | 0.46 |
ENST00000423350.1
|
TCN2
|
transcobalamin II |
chr22_-_20367797 | 0.46 |
ENST00000424787.2
|
GGTLC3
|
gamma-glutamyltransferase light chain 3 |
chr2_-_208030295 | 0.46 |
ENST00000458272.1
|
KLF7
|
Kruppel-like factor 7 (ubiquitous) |
chr17_+_79968655 | 0.46 |
ENST00000583744.1
|
ASPSCR1
|
alveolar soft part sarcoma chromosome region, candidate 1 |
chr15_-_74726283 | 0.46 |
ENST00000543145.2
|
SEMA7A
|
semaphorin 7A, GPI membrane anchor (John Milton Hagen blood group) |
chr7_+_139528952 | 0.45 |
ENST00000416849.2
ENST00000436047.2 ENST00000414508.2 ENST00000448866.1 |
TBXAS1
|
thromboxane A synthase 1 (platelet) |
chr18_+_13217965 | 0.45 |
ENST00000587905.1
|
LDLRAD4
|
low density lipoprotein receptor class A domain containing 4 |
chr10_+_81891416 | 0.45 |
ENST00000372270.2
|
PLAC9
|
placenta-specific 9 |
chr22_+_31003190 | 0.45 |
ENST00000407817.3
|
TCN2
|
transcobalamin II |
chr19_+_41222998 | 0.45 |
ENST00000263370.2
|
ITPKC
|
inositol-trisphosphate 3-kinase C |
chr22_-_45608324 | 0.45 |
ENST00000496226.1
ENST00000251993.7 |
KIAA0930
|
KIAA0930 |
chr9_+_131133598 | 0.45 |
ENST00000372853.4
ENST00000452446.1 ENST00000372850.1 ENST00000372847.1 |
URM1
|
ubiquitin related modifier 1 |
chr18_+_72922710 | 0.45 |
ENST00000322038.5
|
TSHZ1
|
teashirt zinc finger homeobox 1 |
chr18_+_77794446 | 0.45 |
ENST00000262197.7
|
RBFA
|
ribosome binding factor A (putative) |
chr20_+_1875378 | 0.45 |
ENST00000356025.3
|
SIRPA
|
signal-regulatory protein alpha |
chr3_+_126243126 | 0.44 |
ENST00000319340.2
|
CHST13
|
carbohydrate (chondroitin 4) sulfotransferase 13 |
chr19_+_44331555 | 0.44 |
ENST00000590950.1
|
ZNF283
|
zinc finger protein 283 |
chr11_+_67777751 | 0.44 |
ENST00000316367.6
ENST00000007633.8 ENST00000342456.6 |
ALDH3B1
|
aldehyde dehydrogenase 3 family, member B1 |
chr19_-_3557401 | 0.44 |
ENST00000389395.3
ENST00000398558.4 |
MFSD12
|
major facilitator superfamily domain containing 12 |
chr11_+_637246 | 0.44 |
ENST00000176183.5
|
DRD4
|
dopamine receptor D4 |
chr3_-_47950745 | 0.44 |
ENST00000429422.1
|
MAP4
|
microtubule-associated protein 4 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.3 | 1.0 | GO:0048075 | positive regulation of eye pigmentation(GO:0048075) |
0.3 | 1.0 | GO:0001300 | chronological cell aging(GO:0001300) |
0.3 | 1.1 | GO:1901594 | detection of temperature stimulus involved in thermoception(GO:0050960) response to capsazepine(GO:1901594) |
0.3 | 0.8 | GO:0006427 | histidyl-tRNA aminoacylation(GO:0006427) |
0.3 | 1.8 | GO:2000035 | regulation of stem cell division(GO:2000035) |
0.3 | 1.5 | GO:0033591 | response to L-ascorbic acid(GO:0033591) |
0.3 | 1.0 | GO:1903803 | glutamine secretion(GO:0010585) L-glutamine import(GO:0036229) L-glutamine import into cell(GO:1903803) |
0.2 | 0.7 | GO:0060018 | astrocyte fate commitment(GO:0060018) |
0.2 | 0.9 | GO:0050712 | negative regulation of interleukin-1 alpha production(GO:0032690) negative regulation of interleukin-1 alpha secretion(GO:0050712) |
0.2 | 0.7 | GO:0061537 | glycine secretion(GO:0061536) glycine secretion, neurotransmission(GO:0061537) |
0.2 | 0.6 | GO:0003147 | neural crest cell migration involved in heart formation(GO:0003147) anterior neural tube closure(GO:0061713) cellular response to folic acid(GO:0071231) |
0.2 | 0.8 | GO:0061364 | apoptotic process involved in luteolysis(GO:0061364) |
0.2 | 0.6 | GO:1903572 | regulation of protein kinase D signaling(GO:1903570) positive regulation of protein kinase D signaling(GO:1903572) |
0.2 | 0.6 | GO:0008052 | sensory organ boundary specification(GO:0008052) formation of organ boundary(GO:0010160) taste bud development(GO:0061193) |
0.2 | 1.0 | GO:1904139 | mammary gland fat development(GO:0060611) positive regulation of macrophage colony-stimulating factor signaling pathway(GO:1902228) positive regulation of response to macrophage colony-stimulating factor(GO:1903971) positive regulation of cellular response to macrophage colony-stimulating factor stimulus(GO:1903974) microglial cell migration(GO:1904124) regulation of microglial cell migration(GO:1904139) positive regulation of microglial cell migration(GO:1904141) |
0.2 | 0.6 | GO:1905000 | regulation of membrane repolarization during atrial cardiac muscle cell action potential(GO:1905000) |
0.2 | 0.5 | GO:0060738 | positive regulation of immature T cell proliferation in thymus(GO:0033092) right lung development(GO:0060458) primary prostatic bud elongation(GO:0060516) epithelial-mesenchymal signaling involved in prostate gland development(GO:0060738) |
0.2 | 0.5 | GO:1901842 | negative regulation of high voltage-gated calcium channel activity(GO:1901842) |
0.2 | 0.5 | GO:0046603 | negative regulation of mitotic centrosome separation(GO:0046603) |
0.2 | 0.7 | GO:1905224 | clathrin-coated pit assembly(GO:1905224) |
0.2 | 0.5 | GO:1904211 | membrane protein proteolysis involved in retrograde protein transport, ER to cytosol(GO:1904211) |
0.2 | 0.5 | GO:0061394 | regulation of transcription from RNA polymerase II promoter in response to arsenic-containing substance(GO:0061394) |
0.2 | 0.2 | GO:0021986 | epithalamus development(GO:0021538) habenula development(GO:0021986) |
0.2 | 0.5 | GO:0046521 | sphingoid catabolic process(GO:0046521) |
0.2 | 0.7 | GO:1904199 | positive regulation of regulation of vascular smooth muscle cell membrane depolarization(GO:1904199) regulation of vascular smooth muscle cell membrane depolarization(GO:1990736) |
0.2 | 2.8 | GO:1901750 | leukotriene D4 metabolic process(GO:1901748) leukotriene D4 biosynthetic process(GO:1901750) |
0.2 | 0.6 | GO:0042351 | 'de novo' GDP-L-fucose biosynthetic process(GO:0042351) |
0.1 | 0.4 | GO:0071460 | cellular response to cell-matrix adhesion(GO:0071460) |
0.1 | 1.7 | GO:0015889 | cobalt ion transport(GO:0006824) cobalamin transport(GO:0015889) |
0.1 | 0.5 | GO:0006218 | uridine catabolic process(GO:0006218) |
0.1 | 0.5 | GO:0046338 | phosphatidylethanolamine catabolic process(GO:0046338) |
0.1 | 0.4 | GO:0021718 | superior olivary nucleus development(GO:0021718) superior olivary nucleus maturation(GO:0021722) |
0.1 | 0.4 | GO:0006117 | acetaldehyde metabolic process(GO:0006117) |
0.1 | 0.4 | GO:0072356 | chromosome passenger complex localization to kinetochore(GO:0072356) |
0.1 | 0.4 | GO:0034085 | establishment of sister chromatid cohesion(GO:0034085) cohesin loading(GO:0071921) regulation of cohesin loading(GO:0071922) |
0.1 | 0.5 | GO:1901205 | regulation of adrenergic receptor signaling pathway involved in heart process(GO:1901204) negative regulation of adrenergic receptor signaling pathway involved in heart process(GO:1901205) |
0.1 | 0.7 | GO:0042335 | cuticle development(GO:0042335) |
0.1 | 0.5 | GO:0098968 | neurotransmitter receptor transport postsynaptic membrane to endosome(GO:0098968) |
0.1 | 0.6 | GO:0009107 | lipoate biosynthetic process(GO:0009107) |
0.1 | 0.3 | GO:0045083 | negative regulation of interleukin-12 biosynthetic process(GO:0045083) |
0.1 | 1.0 | GO:0072144 | glomerular mesangial cell development(GO:0072144) |
0.1 | 0.3 | GO:0021893 | regulation of transcription from RNA polymerase II promoter involved in forebrain neuron fate commitment(GO:0021882) cerebral cortex GABAergic interneuron fate commitment(GO:0021893) positive regulation of neural retina development(GO:0061075) positive regulation of retina development in camera-type eye(GO:1902868) positive regulation of amacrine cell differentiation(GO:1902871) |
0.1 | 0.8 | GO:0097396 | response to interleukin-17(GO:0097396) cellular response to interleukin-17(GO:0097398) |
0.1 | 0.5 | GO:0090341 | negative regulation of secretion of lysosomal enzymes(GO:0090341) |
0.1 | 0.4 | GO:0001555 | oocyte growth(GO:0001555) |
0.1 | 0.3 | GO:1903033 | regulation of microtubule plus-end binding(GO:1903031) positive regulation of microtubule plus-end binding(GO:1903033) |
0.1 | 0.3 | GO:0019732 | antifungal humoral response(GO:0019732) |
0.1 | 0.6 | GO:0030037 | actin filament reorganization involved in cell cycle(GO:0030037) |
0.1 | 0.5 | GO:0014835 | myoblast differentiation involved in skeletal muscle regeneration(GO:0014835) |
0.1 | 0.4 | GO:0098582 | innate vocalization behavior(GO:0098582) |
0.1 | 0.7 | GO:0061767 | negative regulation of lung blood pressure(GO:0061767) |
0.1 | 0.3 | GO:0060827 | regulation of canonical Wnt signaling pathway involved in neural plate anterior/posterior pattern formation(GO:0060827) negative regulation of canonical Wnt signaling pathway involved in neural plate anterior/posterior pattern formation(GO:0060829) |
0.1 | 1.8 | GO:0015886 | heme transport(GO:0015886) |
0.1 | 0.9 | GO:0007288 | sperm axoneme assembly(GO:0007288) |
0.1 | 0.4 | GO:0061073 | ciliary body morphogenesis(GO:0061073) |
0.1 | 0.5 | GO:0070901 | mitochondrial tRNA methylation(GO:0070901) |
0.1 | 0.3 | GO:2000097 | regulation of smooth muscle cell-matrix adhesion(GO:2000097) |
0.1 | 0.4 | GO:0060023 | soft palate development(GO:0060023) |
0.1 | 0.4 | GO:0000354 | cis assembly of pre-catalytic spliceosome(GO:0000354) |
0.1 | 0.4 | GO:0006601 | creatine biosynthetic process(GO:0006601) |
0.1 | 0.3 | GO:0061743 | motor learning(GO:0061743) |
0.1 | 0.3 | GO:0046416 | D-amino acid metabolic process(GO:0046416) |
0.1 | 0.6 | GO:0019075 | virus maturation(GO:0019075) |
0.1 | 0.5 | GO:0016321 | female meiosis chromosome segregation(GO:0016321) |
0.1 | 0.3 | GO:0006624 | vacuolar protein processing(GO:0006624) |
0.1 | 0.3 | GO:0046271 | phenylpropanoid catabolic process(GO:0046271) |
0.1 | 0.3 | GO:0019417 | sulfur oxidation(GO:0019417) |
0.1 | 0.5 | GO:1902045 | negative regulation of Fas signaling pathway(GO:1902045) positive regulation of blood vessel remodeling(GO:2000504) |
0.1 | 0.5 | GO:0051012 | microtubule sliding(GO:0051012) |
0.1 | 0.5 | GO:0000720 | pyrimidine dimer repair by nucleotide-excision repair(GO:0000720) |
0.1 | 0.4 | GO:0044855 | plasma membrane raft distribution(GO:0044855) plasma membrane raft localization(GO:0044856) plasma membrane raft polarization(GO:0044858) regulation of plasma membrane raft polarization(GO:1903906) |
0.1 | 0.3 | GO:0035616 | histone H2B conserved C-terminal lysine deubiquitination(GO:0035616) |
0.1 | 0.2 | GO:0000349 | generation of catalytic spliceosome for first transesterification step(GO:0000349) |
0.1 | 0.2 | GO:1990654 | sebum secreting cell proliferation(GO:1990654) |
0.1 | 0.7 | GO:0010593 | negative regulation of lamellipodium assembly(GO:0010593) |
0.1 | 0.8 | GO:0032264 | IMP salvage(GO:0032264) |
0.1 | 0.4 | GO:0060010 | Sertoli cell fate commitment(GO:0060010) |
0.1 | 0.4 | GO:0034227 | tRNA thio-modification(GO:0034227) |
0.1 | 1.0 | GO:0043435 | response to corticotropin-releasing hormone(GO:0043435) cellular response to corticotropin-releasing hormone stimulus(GO:0071376) |
0.1 | 0.5 | GO:0032455 | nerve growth factor processing(GO:0032455) |
0.1 | 0.4 | GO:0003057 | regulation of the force of heart contraction by chemical signal(GO:0003057) |
0.1 | 0.4 | GO:0061034 | olfactory bulb mitral cell layer development(GO:0061034) |
0.1 | 0.5 | GO:2000048 | negative regulation of cell-cell adhesion mediated by cadherin(GO:2000048) |
0.1 | 0.3 | GO:0010513 | positive regulation of phosphatidylinositol biosynthetic process(GO:0010513) |
0.1 | 0.1 | GO:0034204 | lipid translocation(GO:0034204) |
0.1 | 0.2 | GO:0060166 | olfactory pit development(GO:0060166) |
0.1 | 1.0 | GO:0035331 | negative regulation of hippo signaling(GO:0035331) |
0.1 | 0.6 | GO:1903361 | protein localization to basolateral plasma membrane(GO:1903361) |
0.1 | 0.8 | GO:2000194 | regulation of female gonad development(GO:2000194) |
0.1 | 0.2 | GO:2000646 | positive regulation of receptor catabolic process(GO:2000646) |
0.1 | 0.6 | GO:2000491 | positive regulation of hepatic stellate cell activation(GO:2000491) |
0.1 | 1.2 | GO:0032836 | glomerular basement membrane development(GO:0032836) |
0.1 | 0.7 | GO:0017062 | respiratory chain complex III assembly(GO:0017062) mitochondrial respiratory chain complex III assembly(GO:0034551) mitochondrial respiratory chain complex III biogenesis(GO:0097033) |
0.1 | 0.6 | GO:0043950 | positive regulation of cAMP-mediated signaling(GO:0043950) |
0.1 | 0.3 | GO:0043553 | vascular endothelial growth factor receptor-2 signaling pathway(GO:0036324) negative regulation of phosphatidylinositol 3-kinase activity(GO:0043553) |
0.1 | 0.3 | GO:0086043 | bundle of His cell to Purkinje myocyte signaling(GO:0086028) bundle of His cell action potential(GO:0086043) |
0.1 | 0.2 | GO:0006102 | isocitrate metabolic process(GO:0006102) |
0.1 | 0.3 | GO:0071492 | cellular response to UV-A(GO:0071492) |
0.1 | 0.4 | GO:0008065 | establishment of blood-nerve barrier(GO:0008065) |
0.1 | 0.8 | GO:0006689 | ganglioside catabolic process(GO:0006689) |
0.1 | 0.4 | GO:0070221 | sulfide oxidation(GO:0019418) sulfide oxidation, using sulfide:quinone oxidoreductase(GO:0070221) |
0.1 | 0.3 | GO:0002432 | granuloma formation(GO:0002432) |
0.1 | 0.3 | GO:0048549 | positive regulation of pinocytosis(GO:0048549) |
0.1 | 0.4 | GO:0071350 | interleukin-15-mediated signaling pathway(GO:0035723) cellular response to interleukin-15(GO:0071350) |
0.1 | 0.6 | GO:0031022 | nuclear migration along microfilament(GO:0031022) |
0.1 | 0.6 | GO:0006933 | negative regulation of cell adhesion involved in substrate-bound cell migration(GO:0006933) |
0.1 | 0.4 | GO:0031914 | negative regulation of synaptic plasticity(GO:0031914) |
0.1 | 0.4 | GO:2000503 | positive regulation of natural killer cell chemotaxis(GO:2000503) |
0.1 | 1.5 | GO:0043949 | regulation of cAMP-mediated signaling(GO:0043949) |
0.1 | 0.1 | GO:0046532 | regulation of photoreceptor cell differentiation(GO:0046532) |
0.1 | 1.0 | GO:0006307 | DNA dealkylation involved in DNA repair(GO:0006307) |
0.1 | 0.7 | GO:0006570 | tyrosine metabolic process(GO:0006570) |
0.1 | 0.2 | GO:0030821 | negative regulation of cyclic nucleotide catabolic process(GO:0030806) negative regulation of cAMP catabolic process(GO:0030821) negative regulation of purine nucleotide catabolic process(GO:0033122) |
0.1 | 0.5 | GO:0000707 | meiotic DNA recombinase assembly(GO:0000707) |
0.1 | 0.9 | GO:0090385 | phagosome-lysosome fusion(GO:0090385) |
0.1 | 0.3 | GO:0050703 | interleukin-1 alpha secretion(GO:0050703) |
0.1 | 0.4 | GO:0060672 | epithelial cell differentiation involved in embryonic placenta development(GO:0060671) epithelial cell morphogenesis involved in placental branching(GO:0060672) |
0.1 | 0.3 | GO:0010693 | negative regulation of alkaline phosphatase activity(GO:0010693) |
0.1 | 0.2 | GO:0032286 | central nervous system myelin maintenance(GO:0032286) |
0.1 | 0.6 | GO:0044351 | macropinocytosis(GO:0044351) |
0.1 | 0.3 | GO:0010760 | negative regulation of macrophage chemotaxis(GO:0010760) |
0.1 | 0.4 | GO:0072674 | multinuclear osteoclast differentiation(GO:0072674) osteoclast fusion(GO:0072675) |
0.1 | 1.0 | GO:0010991 | negative regulation of SMAD protein complex assembly(GO:0010991) |
0.1 | 0.4 | GO:0032417 | positive regulation of sodium:proton antiporter activity(GO:0032417) |
0.1 | 0.7 | GO:0030951 | establishment or maintenance of microtubule cytoskeleton polarity(GO:0030951) |
0.1 | 0.2 | GO:0046586 | regulation of calcium-dependent cell-cell adhesion(GO:0046586) |
0.1 | 1.6 | GO:0046339 | diacylglycerol metabolic process(GO:0046339) |
0.1 | 0.6 | GO:0051388 | positive regulation of neurotrophin TRK receptor signaling pathway(GO:0051388) |
0.1 | 0.3 | GO:0051490 | negative regulation of filopodium assembly(GO:0051490) |
0.1 | 0.6 | GO:0030238 | male sex determination(GO:0030238) |
0.1 | 0.5 | GO:0070995 | NADPH oxidation(GO:0070995) |
0.1 | 0.2 | GO:0052026 | modulation by virus of host transcription(GO:0019056) positive regulation of sprouting of injured axon(GO:0048687) positive regulation of axon extension involved in regeneration(GO:0048691) modulation by symbiont of host transcription(GO:0052026) |
0.1 | 1.0 | GO:0071027 | nuclear RNA surveillance(GO:0071027) nuclear mRNA surveillance(GO:0071028) |
0.1 | 0.1 | GO:0048867 | stem cell fate determination(GO:0048867) |
0.1 | 0.3 | GO:0002378 | immunoglobulin biosynthetic process(GO:0002378) |
0.1 | 0.6 | GO:0006477 | protein sulfation(GO:0006477) |
0.1 | 0.6 | GO:0021527 | spinal cord association neuron differentiation(GO:0021527) |
0.1 | 0.2 | GO:2000909 | regulation of cholesterol import(GO:0060620) regulation of sterol import(GO:2000909) |
0.1 | 0.5 | GO:0006049 | UDP-N-acetylglucosamine catabolic process(GO:0006049) |
0.1 | 0.4 | GO:0014816 | skeletal muscle satellite cell differentiation(GO:0014816) |
0.0 | 0.8 | GO:0016540 | protein autoprocessing(GO:0016540) |
0.0 | 0.1 | GO:0033037 | polysaccharide localization(GO:0033037) |
0.0 | 0.4 | GO:0030579 | ubiquitin-dependent SMAD protein catabolic process(GO:0030579) |
0.0 | 0.1 | GO:0046495 | nicotinamide riboside catabolic process(GO:0006738) nicotinamide riboside metabolic process(GO:0046495) pyridine nucleoside metabolic process(GO:0070637) pyridine nucleoside catabolic process(GO:0070638) |
0.0 | 0.5 | GO:0002329 | pre-B cell differentiation(GO:0002329) |
0.0 | 0.6 | GO:0035507 | regulation of myosin-light-chain-phosphatase activity(GO:0035507) |
0.0 | 0.2 | GO:0046668 | negative regulation of cellular pH reduction(GO:0032848) CD8-positive, alpha-beta T cell lineage commitment(GO:0043375) regulation of retinal cell programmed cell death(GO:0046668) negative regulation of retinal cell programmed cell death(GO:0046671) |
0.0 | 0.4 | GO:0034350 | regulation of glial cell apoptotic process(GO:0034350) negative regulation of glial cell apoptotic process(GO:0034351) |
0.0 | 0.1 | GO:0048003 | synaptic vesicle recycling via endosome(GO:0036466) antigen processing and presentation of lipid antigen via MHC class Ib(GO:0048003) antigen processing and presentation, exogenous lipid antigen via MHC class Ib(GO:0048007) |
0.0 | 0.5 | GO:0006931 | substrate-dependent cell migration, cell attachment to substrate(GO:0006931) |
0.0 | 0.3 | GO:0010002 | cardioblast differentiation(GO:0010002) |
0.0 | 0.2 | GO:1900148 | Schwann cell proliferation involved in axon regeneration(GO:0014011) negative regulation of Schwann cell migration(GO:1900148) regulation of Schwann cell proliferation involved in axon regeneration(GO:1905044) negative regulation of Schwann cell proliferation involved in axon regeneration(GO:1905045) |
0.0 | 0.3 | GO:0032487 | regulation of Rap protein signal transduction(GO:0032487) |
0.0 | 0.2 | GO:0006238 | CMP salvage(GO:0006238) CMP biosynthetic process(GO:0009224) CMP metabolic process(GO:0046035) |
0.0 | 0.4 | GO:0036155 | acylglycerol acyl-chain remodeling(GO:0036155) |
0.0 | 0.1 | GO:0036493 | positive regulation of translation in response to endoplasmic reticulum stress(GO:0036493) |
0.0 | 0.1 | GO:1904204 | skeletal muscle hypertrophy(GO:0014734) regulation of skeletal muscle hypertrophy(GO:1904204) |
0.0 | 0.3 | GO:0043314 | negative regulation of neutrophil degranulation(GO:0043314) |
0.0 | 0.4 | GO:0061373 | mammillary body development(GO:0021767) mammillary axonal complex development(GO:0061373) positive regulation of lens fiber cell differentiation(GO:1902748) |
0.0 | 0.8 | GO:0019388 | galactose catabolic process(GO:0019388) |
0.0 | 0.4 | GO:0060414 | aorta smooth muscle tissue morphogenesis(GO:0060414) |
0.0 | 0.7 | GO:0031953 | negative regulation of protein autophosphorylation(GO:0031953) |
0.0 | 0.5 | GO:0018231 | peptidyl-L-cysteine S-palmitoylation(GO:0018230) peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine(GO:0018231) |
0.0 | 0.2 | GO:1900111 | positive regulation of histone H3-K9 dimethylation(GO:1900111) |
0.0 | 0.2 | GO:0003199 | endocardial cushion to mesenchymal transition involved in heart valve formation(GO:0003199) |
0.0 | 0.7 | GO:0090286 | cytoskeletal anchoring at nuclear membrane(GO:0090286) |
0.0 | 1.0 | GO:0003334 | keratinocyte development(GO:0003334) |
0.0 | 0.4 | GO:0034141 | positive regulation of toll-like receptor 3 signaling pathway(GO:0034141) |
0.0 | 0.2 | GO:2000189 | positive regulation of cholesterol homeostasis(GO:2000189) |
0.0 | 0.4 | GO:0030259 | lipid glycosylation(GO:0030259) |
0.0 | 0.1 | GO:0002101 | tRNA wobble cytosine modification(GO:0002101) |
0.0 | 0.1 | GO:0006286 | base-excision repair, base-free sugar-phosphate removal(GO:0006286) |
0.0 | 0.1 | GO:0043012 | regulation of fusion of sperm to egg plasma membrane(GO:0043012) |
0.0 | 0.3 | GO:0010793 | regulation of mRNA export from nucleus(GO:0010793) |
0.0 | 0.2 | GO:0007181 | transforming growth factor beta receptor complex assembly(GO:0007181) |
0.0 | 0.8 | GO:0060907 | positive regulation of macrophage cytokine production(GO:0060907) |
0.0 | 0.3 | GO:0035524 | L-alanine transport(GO:0015808) proline transmembrane transport(GO:0035524) |
0.0 | 0.1 | GO:0015842 | aminergic neurotransmitter loading into synaptic vesicle(GO:0015842) isoquinoline alkaloid metabolic process(GO:0033076) |
0.0 | 0.2 | GO:0010133 | proline catabolic process(GO:0006562) proline catabolic process to glutamate(GO:0010133) |
0.0 | 0.1 | GO:0021812 | neuronal-glial interaction involved in cerebral cortex radial glia guided migration(GO:0021812) |
0.0 | 0.4 | GO:0018401 | peptidyl-proline hydroxylation to 4-hydroxy-L-proline(GO:0018401) |
0.0 | 0.1 | GO:1900226 | negative regulation of NLRP3 inflammasome complex assembly(GO:1900226) |
0.0 | 0.4 | GO:0051574 | positive regulation of histone H3-K9 methylation(GO:0051574) |
0.0 | 0.4 | GO:0001778 | plasma membrane repair(GO:0001778) |
0.0 | 0.3 | GO:1900625 | regulation of monocyte aggregation(GO:1900623) positive regulation of monocyte aggregation(GO:1900625) |
0.0 | 0.2 | GO:0043163 | cell envelope organization(GO:0043163) external encapsulating structure organization(GO:0045229) |
0.0 | 0.5 | GO:0002191 | cap-dependent translational initiation(GO:0002191) |
0.0 | 0.2 | GO:0046985 | negative regulation of megakaryocyte differentiation(GO:0045653) positive regulation of hemoglobin biosynthetic process(GO:0046985) |
0.0 | 0.3 | GO:0098967 | exocytic insertion of neurotransmitter receptor to plasma membrane(GO:0098881) exocytic insertion of neurotransmitter receptor to postsynaptic membrane(GO:0098967) |
0.0 | 0.2 | GO:0010940 | positive regulation of necrotic cell death(GO:0010940) |
0.0 | 0.4 | GO:1902659 | regulation of glucose mediated signaling pathway(GO:1902659) |
0.0 | 0.3 | GO:2001206 | positive regulation of osteoclast development(GO:2001206) |
0.0 | 0.4 | GO:0031118 | rRNA pseudouridine synthesis(GO:0031118) |
0.0 | 0.3 | GO:0000066 | mitochondrial ornithine transport(GO:0000066) |
0.0 | 0.1 | GO:1900108 | negative regulation of nodal signaling pathway(GO:1900108) |
0.0 | 0.4 | GO:0050910 | detection of mechanical stimulus involved in sensory perception of sound(GO:0050910) |
0.0 | 0.2 | GO:0051121 | hepoxilin metabolic process(GO:0051121) hepoxilin biosynthetic process(GO:0051122) |
0.0 | 0.6 | GO:0043931 | ossification involved in bone maturation(GO:0043931) |
0.0 | 0.3 | GO:0018107 | peptidyl-threonine phosphorylation(GO:0018107) peptidyl-threonine modification(GO:0018210) |
0.0 | 0.1 | GO:0090274 | regulation of somatostatin secretion(GO:0090273) positive regulation of somatostatin secretion(GO:0090274) |
0.0 | 0.3 | GO:0000055 | ribosomal large subunit export from nucleus(GO:0000055) |
0.0 | 0.3 | GO:0002227 | innate immune response in mucosa(GO:0002227) |
0.0 | 0.4 | GO:0072383 | plus-end-directed vesicle transport along microtubule(GO:0072383) |
0.0 | 0.1 | GO:0090187 | positive regulation of high-density lipoprotein particle assembly(GO:0090108) positive regulation of pancreatic juice secretion(GO:0090187) positive regulation of secretion of lysosomal enzymes(GO:0090340) |
0.0 | 0.1 | GO:0035262 | gonad morphogenesis(GO:0035262) |
0.0 | 0.4 | GO:0006621 | protein retention in ER lumen(GO:0006621) |
0.0 | 0.1 | GO:0060011 | Sertoli cell proliferation(GO:0060011) |
0.0 | 0.2 | GO:1902499 | positive regulation of protein autoubiquitination(GO:1902499) |
0.0 | 0.4 | GO:0032000 | positive regulation of fatty acid beta-oxidation(GO:0032000) |
0.0 | 0.2 | GO:0033490 | cholesterol biosynthetic process via desmosterol(GO:0033489) cholesterol biosynthetic process via lathosterol(GO:0033490) |
0.0 | 0.1 | GO:0050902 | leukocyte adhesive activation(GO:0050902) |
0.0 | 0.2 | GO:0046898 | response to cycloheximide(GO:0046898) |
0.0 | 0.3 | GO:0002084 | protein depalmitoylation(GO:0002084) |
0.0 | 0.3 | GO:1905232 | cellular response to L-glutamate(GO:1905232) |
0.0 | 0.2 | GO:1903527 | positive regulation of membrane tubulation(GO:1903527) |
0.0 | 0.1 | GO:0033564 | anterior/posterior axon guidance(GO:0033564) |
0.0 | 0.2 | GO:0006982 | response to lipid hydroperoxide(GO:0006982) |
0.0 | 0.3 | GO:0061087 | positive regulation of histone H3-K27 methylation(GO:0061087) |
0.0 | 0.1 | GO:0007056 | spindle assembly involved in female meiosis(GO:0007056) |
0.0 | 0.4 | GO:1990440 | positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress(GO:1990440) |
0.0 | 0.5 | GO:0045741 | positive regulation of epidermal growth factor-activated receptor activity(GO:0045741) |
0.0 | 0.5 | GO:0019371 | cyclooxygenase pathway(GO:0019371) |
0.0 | 0.2 | GO:0033133 | positive regulation of glucokinase activity(GO:0033133) positive regulation of hexokinase activity(GO:1903301) |
0.0 | 0.1 | GO:0018315 | molybdenum incorporation into molybdenum-molybdopterin complex(GO:0018315) metal incorporation into metallo-molybdopterin complex(GO:0042040) glycine receptor clustering(GO:0072579) |
0.0 | 0.1 | GO:0050916 | sensory perception of sweet taste(GO:0050916) |
0.0 | 0.2 | GO:0014827 | intestine smooth muscle contraction(GO:0014827) |
0.0 | 0.3 | GO:0070307 | lens fiber cell development(GO:0070307) |
0.0 | 0.2 | GO:1900383 | regulation of synaptic plasticity by receptor localization to synapse(GO:1900383) |
0.0 | 0.2 | GO:0044375 | regulation of peroxisome size(GO:0044375) |
0.0 | 0.6 | GO:0040033 | miRNA mediated inhibition of translation(GO:0035278) negative regulation of translation, ncRNA-mediated(GO:0040033) regulation of translation, ncRNA-mediated(GO:0045974) |
0.0 | 0.4 | GO:0046185 | aldehyde catabolic process(GO:0046185) |
0.0 | 0.4 | GO:0014883 | transition between fast and slow fiber(GO:0014883) |
0.0 | 0.8 | GO:0060065 | uterus development(GO:0060065) |
0.0 | 0.4 | GO:2000615 | regulation of histone H3-K9 acetylation(GO:2000615) |
0.0 | 0.3 | GO:0017182 | peptidyl-diphthamide metabolic process(GO:0017182) peptidyl-diphthamide biosynthetic process from peptidyl-histidine(GO:0017183) |
0.0 | 0.2 | GO:2001295 | malonyl-CoA biosynthetic process(GO:2001295) |
0.0 | 0.2 | GO:0033277 | abortive mitotic cell cycle(GO:0033277) |
0.0 | 0.4 | GO:0072718 | response to cisplatin(GO:0072718) |
0.0 | 0.3 | GO:0022417 | protein maturation by protein folding(GO:0022417) |
0.0 | 0.3 | GO:0061088 | regulation of sequestering of zinc ion(GO:0061088) |
0.0 | 0.8 | GO:2000369 | regulation of clathrin-mediated endocytosis(GO:2000369) |
0.0 | 0.4 | GO:0051823 | regulation of synapse structural plasticity(GO:0051823) |
0.0 | 0.2 | GO:0014807 | regulation of somitogenesis(GO:0014807) |
0.0 | 1.2 | GO:0070536 | protein K63-linked deubiquitination(GO:0070536) |
0.0 | 0.6 | GO:0006884 | cell volume homeostasis(GO:0006884) |
0.0 | 0.7 | GO:0045730 | respiratory burst(GO:0045730) |
0.0 | 0.3 | GO:0048227 | plasma membrane to endosome transport(GO:0048227) |
0.0 | 0.6 | GO:0007191 | adenylate cyclase-activating dopamine receptor signaling pathway(GO:0007191) |
0.0 | 0.4 | GO:0014832 | urinary bladder smooth muscle contraction(GO:0014832) urinary tract smooth muscle contraction(GO:0014848) |
0.0 | 0.4 | GO:2000096 | positive regulation of Wnt signaling pathway, planar cell polarity pathway(GO:2000096) |
0.0 | 0.0 | GO:0072137 | condensed mesenchymal cell proliferation(GO:0072137) |
0.0 | 0.4 | GO:0070914 | UV-damage excision repair(GO:0070914) |
0.0 | 0.2 | GO:2000795 | negative regulation of epithelial cell proliferation involved in lung morphogenesis(GO:2000795) |
0.0 | 0.4 | GO:1901538 | DNA methylation involved in embryo development(GO:0043045) changes to DNA methylation involved in embryo development(GO:1901538) |
0.0 | 0.4 | GO:0032740 | positive regulation of interleukin-17 production(GO:0032740) |
0.0 | 0.9 | GO:0090200 | positive regulation of release of cytochrome c from mitochondria(GO:0090200) |
0.0 | 0.1 | GO:0050668 | cellular response to phosphate starvation(GO:0016036) regulation of sulfur amino acid metabolic process(GO:0031335) positive regulation of sulfur amino acid metabolic process(GO:0031337) regulation of homocysteine metabolic process(GO:0050666) positive regulation of homocysteine metabolic process(GO:0050668) |
0.0 | 0.2 | GO:0070935 | 3'-UTR-mediated mRNA stabilization(GO:0070935) |
0.0 | 0.2 | GO:0007000 | nucleolus organization(GO:0007000) |
0.0 | 0.1 | GO:0060578 | subthalamic nucleus development(GO:0021763) prolactin secreting cell differentiation(GO:0060127) pulmonary vein morphogenesis(GO:0060577) superior vena cava morphogenesis(GO:0060578) |
0.0 | 0.1 | GO:0001806 | type IV hypersensitivity(GO:0001806) regulation of type IV hypersensitivity(GO:0001807) negative regulation of type IV hypersensitivity(GO:0001808) |
0.0 | 0.2 | GO:0006268 | DNA unwinding involved in DNA replication(GO:0006268) |
0.0 | 0.1 | GO:0060748 | tertiary branching involved in mammary gland duct morphogenesis(GO:0060748) |
0.0 | 0.2 | GO:0000389 | mRNA 3'-splice site recognition(GO:0000389) |
0.0 | 0.6 | GO:0001964 | startle response(GO:0001964) |
0.0 | 0.4 | GO:0023041 | neuronal signal transduction(GO:0023041) |
0.0 | 0.6 | GO:0006895 | Golgi to endosome transport(GO:0006895) |
0.0 | 0.4 | GO:0033539 | fatty acid beta-oxidation using acyl-CoA dehydrogenase(GO:0033539) |
0.0 | 0.3 | GO:0000712 | resolution of meiotic recombination intermediates(GO:0000712) |
0.0 | 0.5 | GO:0071168 | protein localization to chromatin(GO:0071168) |
0.0 | 0.3 | GO:0007172 | signal complex assembly(GO:0007172) |
0.0 | 0.2 | GO:0090038 | negative regulation of protein kinase C signaling(GO:0090038) |
0.0 | 0.3 | GO:0007512 | adult heart development(GO:0007512) |
0.0 | 0.2 | GO:0002385 | mucosal immune response(GO:0002385) |
0.0 | 0.2 | GO:0002457 | T cell antigen processing and presentation(GO:0002457) |
0.0 | 0.4 | GO:0048096 | chromatin-mediated maintenance of transcription(GO:0048096) |
0.0 | 0.4 | GO:0051085 | chaperone mediated protein folding requiring cofactor(GO:0051085) |
0.0 | 0.3 | GO:0021520 | spinal cord motor neuron cell fate specification(GO:0021520) |
0.0 | 0.2 | GO:0046222 | mycotoxin metabolic process(GO:0043385) aflatoxin metabolic process(GO:0046222) organic heteropentacyclic compound metabolic process(GO:1901376) |
0.0 | 0.1 | GO:0032464 | positive regulation of protein homooligomerization(GO:0032464) |
0.0 | 0.1 | GO:0048749 | compound eye development(GO:0048749) |
0.0 | 0.2 | GO:0019748 | melanin metabolic process(GO:0006582) secondary metabolic process(GO:0019748) |
0.0 | 1.5 | GO:0006893 | Golgi to plasma membrane transport(GO:0006893) |
0.0 | 0.8 | GO:0032878 | regulation of establishment or maintenance of cell polarity(GO:0032878) |
0.0 | 0.4 | GO:0097264 | self proteolysis(GO:0097264) |
0.0 | 0.4 | GO:0016578 | histone deubiquitination(GO:0016578) |
0.0 | 0.9 | GO:0007257 | activation of JUN kinase activity(GO:0007257) |
0.0 | 0.2 | GO:0034447 | very-low-density lipoprotein particle clearance(GO:0034447) |
0.0 | 0.1 | GO:0051084 | 'de novo' posttranslational protein folding(GO:0051084) |
0.0 | 0.4 | GO:0001946 | lymphangiogenesis(GO:0001946) |
0.0 | 0.3 | GO:0002091 | negative regulation of receptor internalization(GO:0002091) |
0.0 | 0.4 | GO:0043567 | regulation of insulin-like growth factor receptor signaling pathway(GO:0043567) |
0.0 | 2.1 | GO:1903955 | positive regulation of protein targeting to mitochondrion(GO:1903955) |
0.0 | 0.2 | GO:0006682 | galactosylceramide biosynthetic process(GO:0006682) galactolipid biosynthetic process(GO:0019375) |
0.0 | 0.2 | GO:0002943 | tRNA dihydrouridine synthesis(GO:0002943) |
0.0 | 0.7 | GO:0046676 | negative regulation of insulin secretion(GO:0046676) |
0.0 | 0.1 | GO:0015015 | heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
0.0 | 0.2 | GO:0015684 | ferrous iron transport(GO:0015684) ferrous iron transmembrane transport(GO:1903874) |
0.0 | 0.1 | GO:0046604 | positive regulation of mitotic centrosome separation(GO:0046604) |
0.0 | 0.1 | GO:1900425 | negative regulation of defense response to bacterium(GO:1900425) |
0.0 | 0.5 | GO:0016338 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules(GO:0016338) |
0.0 | 0.2 | GO:0045218 | zonula adherens maintenance(GO:0045218) |
0.0 | 0.4 | GO:2000651 | positive regulation of sodium ion transmembrane transporter activity(GO:2000651) |
0.0 | 0.3 | GO:0036295 | cellular response to increased oxygen levels(GO:0036295) |
0.0 | 0.1 | GO:0009313 | oligosaccharide catabolic process(GO:0009313) |
0.0 | 0.1 | GO:0002729 | positive regulation of natural killer cell cytokine production(GO:0002729) |
0.0 | 0.1 | GO:0007183 | SMAD protein complex assembly(GO:0007183) |
0.0 | 0.1 | GO:1901894 | regulation of calcium-transporting ATPase activity(GO:1901894) |
0.0 | 0.0 | GO:0044860 | protein localization to plasma membrane raft(GO:0044860) protein transport into plasma membrane raft(GO:0044861) |
0.0 | 0.2 | GO:0050861 | positive regulation of B cell receptor signaling pathway(GO:0050861) |
0.0 | 0.1 | GO:1902951 | negative regulation of dendritic spine maintenance(GO:1902951) |
0.0 | 0.6 | GO:0045671 | negative regulation of osteoclast differentiation(GO:0045671) |
0.0 | 0.5 | GO:0036109 | alpha-linolenic acid metabolic process(GO:0036109) |
0.0 | 0.2 | GO:0010960 | magnesium ion homeostasis(GO:0010960) |
0.0 | 0.1 | GO:1900029 | positive regulation of ruffle assembly(GO:1900029) |
0.0 | 0.2 | GO:0046600 | negative regulation of centriole replication(GO:0046600) |
0.0 | 1.2 | GO:0030574 | collagen catabolic process(GO:0030574) |
0.0 | 0.4 | GO:0032211 | negative regulation of telomere maintenance via telomerase(GO:0032211) |
0.0 | 0.4 | GO:0006904 | vesicle docking involved in exocytosis(GO:0006904) |
0.0 | 0.1 | GO:0043321 | regulation of natural killer cell degranulation(GO:0043321) positive regulation of natural killer cell degranulation(GO:0043323) |
0.0 | 0.5 | GO:0031581 | hemidesmosome assembly(GO:0031581) |
0.0 | 0.1 | GO:0015688 | iron chelate transport(GO:0015688) siderophore transport(GO:0015891) |
0.0 | 0.2 | GO:0034384 | high-density lipoprotein particle clearance(GO:0034384) |
0.0 | 0.1 | GO:0072502 | cellular phosphate ion homeostasis(GO:0030643) cellular divalent inorganic anion homeostasis(GO:0072501) cellular trivalent inorganic anion homeostasis(GO:0072502) |
0.0 | 0.1 | GO:0019348 | dolichol metabolic process(GO:0019348) |
0.0 | 0.3 | GO:0009950 | dorsal/ventral axis specification(GO:0009950) |
0.0 | 0.2 | GO:0019896 | axonal transport of mitochondrion(GO:0019896) |
0.0 | 0.2 | GO:0039536 | negative regulation of RIG-I signaling pathway(GO:0039536) |
0.0 | 0.1 | GO:0008063 | Toll signaling pathway(GO:0008063) |
0.0 | 0.7 | GO:0045773 | positive regulation of axon extension(GO:0045773) |
0.0 | 0.1 | GO:0043686 | co-translational protein modification(GO:0043686) |
0.0 | 0.1 | GO:1904379 | protein localization to cytosolic proteasome complex(GO:1904327) protein localization to cytosolic proteasome complex involved in ERAD pathway(GO:1904379) |
0.0 | 0.3 | GO:2001275 | positive regulation of glucose import in response to insulin stimulus(GO:2001275) |
0.0 | 0.9 | GO:0071377 | cellular response to glucagon stimulus(GO:0071377) |
0.0 | 0.4 | GO:0051865 | protein autoubiquitination(GO:0051865) |
0.0 | 0.2 | GO:0038203 | TORC2 signaling(GO:0038203) |
0.0 | 0.2 | GO:0050774 | negative regulation of dendrite morphogenesis(GO:0050774) |
0.0 | 0.1 | GO:0045743 | positive regulation of fibroblast growth factor receptor signaling pathway(GO:0045743) |
0.0 | 0.3 | GO:0015937 | coenzyme A biosynthetic process(GO:0015937) |
0.0 | 0.1 | GO:0071874 | cellular response to norepinephrine stimulus(GO:0071874) |
0.0 | 0.1 | GO:0051573 | negative regulation of histone H3-K9 methylation(GO:0051573) |
0.0 | 0.2 | GO:0035690 | cellular response to drug(GO:0035690) |
0.0 | 0.1 | GO:0043383 | negative T cell selection(GO:0043383) |
0.0 | 0.7 | GO:1904837 | beta-catenin-TCF complex assembly(GO:1904837) |
0.0 | 0.2 | GO:0006636 | unsaturated fatty acid biosynthetic process(GO:0006636) |
0.0 | 0.1 | GO:0031053 | primary miRNA processing(GO:0031053) |
0.0 | 0.4 | GO:0097194 | execution phase of apoptosis(GO:0097194) |
0.0 | 0.3 | GO:0048536 | spleen development(GO:0048536) |
0.0 | 0.2 | GO:0006293 | nucleotide-excision repair, preincision complex stabilization(GO:0006293) |
0.0 | 0.1 | GO:0019919 | peptidyl-arginine methylation, to asymmetrical-dimethyl arginine(GO:0019919) |
0.0 | 0.4 | GO:0032786 | positive regulation of DNA-templated transcription, elongation(GO:0032786) |
0.0 | 0.1 | GO:0070235 | regulation of activation-induced cell death of T cells(GO:0070235) negative regulation of activation-induced cell death of T cells(GO:0070236) |
0.0 | 0.2 | GO:0006995 | cellular response to nitrogen starvation(GO:0006995) cellular response to nitrogen levels(GO:0043562) |
0.0 | 0.2 | GO:0098779 | mitophagy in response to mitochondrial depolarization(GO:0098779) |
0.0 | 0.6 | GO:0042339 | keratan sulfate metabolic process(GO:0042339) |
0.0 | 0.1 | GO:0060346 | bone trabecula formation(GO:0060346) |
0.0 | 0.2 | GO:0000185 | activation of MAPKKK activity(GO:0000185) |
0.0 | 0.3 | GO:0014046 | dopamine secretion(GO:0014046) regulation of dopamine secretion(GO:0014059) |
0.0 | 0.4 | GO:0045746 | negative regulation of Notch signaling pathway(GO:0045746) |
0.0 | 0.5 | GO:0030866 | cortical actin cytoskeleton organization(GO:0030866) |
0.0 | 0.2 | GO:0042574 | retinal metabolic process(GO:0042574) |
0.0 | 0.3 | GO:0035563 | positive regulation of chromatin binding(GO:0035563) |
0.0 | 0.1 | GO:0035902 | response to immobilization stress(GO:0035902) |
0.0 | 0.2 | GO:0006782 | protoporphyrinogen IX biosynthetic process(GO:0006782) |
0.0 | 0.2 | GO:0070193 | synaptonemal complex assembly(GO:0007130) synaptonemal complex organization(GO:0070193) |
0.0 | 0.2 | GO:0010719 | negative regulation of epithelial to mesenchymal transition(GO:0010719) |
0.0 | 0.3 | GO:1902236 | negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway(GO:1902236) |
0.0 | 0.3 | GO:0006509 | membrane protein ectodomain proteolysis(GO:0006509) |
0.0 | 0.5 | GO:0048488 | synaptic vesicle endocytosis(GO:0048488) |
0.0 | 0.2 | GO:0089711 | L-glutamate transmembrane transport(GO:0089711) |
0.0 | 0.3 | GO:0035435 | phosphate ion transmembrane transport(GO:0035435) |
0.0 | 0.1 | GO:0021942 | radial glia guided migration of Purkinje cell(GO:0021942) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.4 | 1.1 | GO:0001534 | radial spoke(GO:0001534) |
0.3 | 1.0 | GO:0072563 | endothelial microparticle(GO:0072563) |
0.3 | 1.0 | GO:0031085 | BLOC-3 complex(GO:0031085) |
0.2 | 0.6 | GO:0034515 | proteasome storage granule(GO:0034515) |
0.2 | 0.5 | GO:1990622 | CHOP-ATF3 complex(GO:1990622) |
0.1 | 0.6 | GO:0031523 | Myb complex(GO:0031523) |
0.1 | 0.8 | GO:0016035 | zeta DNA polymerase complex(GO:0016035) |
0.1 | 0.4 | GO:0035525 | NF-kappaB p50/p65 complex(GO:0035525) |
0.1 | 0.8 | GO:0070436 | Grb2-EGFR complex(GO:0070436) |
0.1 | 0.5 | GO:0016533 | cyclin-dependent protein kinase 5 holoenzyme complex(GO:0016533) |
0.1 | 1.0 | GO:0005587 | collagen type IV trimer(GO:0005587) |
0.1 | 0.3 | GO:0071821 | FANCM-MHF complex(GO:0071821) |
0.1 | 0.3 | GO:1990032 | parallel fiber(GO:1990032) |
0.1 | 0.6 | GO:1990682 | CSF1-CSF1R complex(GO:1990682) |
0.1 | 0.6 | GO:0008282 | ATP-sensitive potassium channel complex(GO:0008282) |
0.1 | 0.4 | GO:0070931 | Golgi-associated vesicle lumen(GO:0070931) |
0.1 | 0.5 | GO:1990031 | pinceau fiber(GO:1990031) |
0.1 | 0.4 | GO:0097233 | lamellar body membrane(GO:0097232) alveolar lamellar body membrane(GO:0097233) |
0.1 | 0.4 | GO:0090498 | extrinsic component of Golgi membrane(GO:0090498) |
0.1 | 0.5 | GO:0000942 | condensed nuclear chromosome outer kinetochore(GO:0000942) |
0.1 | 0.3 | GO:1990796 | photoreceptor cell terminal bouton(GO:1990796) |
0.1 | 0.4 | GO:0030934 | anchoring collagen complex(GO:0030934) |
0.1 | 0.4 | GO:0071942 | XPC complex(GO:0071942) |
0.1 | 0.7 | GO:0032010 | phagolysosome(GO:0032010) |
0.1 | 0.7 | GO:0070552 | BRISC complex(GO:0070552) |
0.1 | 1.1 | GO:0030478 | actin cap(GO:0030478) |
0.1 | 0.6 | GO:0000138 | Golgi trans cisterna(GO:0000138) |
0.1 | 1.0 | GO:0070652 | HAUS complex(GO:0070652) |
0.1 | 0.5 | GO:0000110 | nucleotide-excision repair factor 1 complex(GO:0000110) |
0.1 | 0.5 | GO:0033063 | Rad51B-Rad51C-Rad51D-XRCC2 complex(GO:0033063) |
0.1 | 0.2 | GO:0005581 | collagen trimer(GO:0005581) |
0.1 | 0.2 | GO:0020005 | symbiont-containing vacuole(GO:0020003) symbiont-containing vacuole membrane(GO:0020005) |
0.1 | 0.9 | GO:0000506 | glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex(GO:0000506) |
0.1 | 0.7 | GO:0071144 | SMAD2-SMAD3 protein complex(GO:0071144) |
0.1 | 0.3 | GO:0065010 | extracellular membrane-bounded organelle(GO:0065010) |
0.1 | 0.5 | GO:0034750 | Scrib-APC-beta-catenin complex(GO:0034750) |
0.1 | 0.5 | GO:0030678 | mitochondrial ribonuclease P complex(GO:0030678) |
0.1 | 0.7 | GO:0005751 | mitochondrial respiratory chain complex IV(GO:0005751) |
0.1 | 0.3 | GO:0030485 | smooth muscle contractile fiber(GO:0030485) |
0.1 | 0.4 | GO:0005899 | insulin receptor complex(GO:0005899) |
0.1 | 0.7 | GO:0005750 | mitochondrial respiratory chain complex III(GO:0005750) respiratory chain complex III(GO:0045275) |
0.0 | 1.4 | GO:0071682 | endocytic vesicle lumen(GO:0071682) |
0.0 | 0.4 | GO:0031012 | extracellular matrix(GO:0031012) |
0.0 | 1.1 | GO:0032591 | dendritic spine membrane(GO:0032591) |
0.0 | 0.6 | GO:0042788 | polysomal ribosome(GO:0042788) |
0.0 | 1.3 | GO:0034993 | microtubule organizing center attachment site(GO:0034992) LINC complex(GO:0034993) |
0.0 | 1.0 | GO:0031362 | anchored component of external side of plasma membrane(GO:0031362) |
0.0 | 0.3 | GO:0070852 | cell body fiber(GO:0070852) |
0.0 | 0.6 | GO:0097025 | MPP7-DLG1-LIN7 complex(GO:0097025) |
0.0 | 0.3 | GO:0070435 | Shc-EGFR complex(GO:0070435) |
0.0 | 0.3 | GO:0005784 | Sec61 translocon complex(GO:0005784) translocon complex(GO:0071256) |
0.0 | 0.4 | GO:0045252 | oxoglutarate dehydrogenase complex(GO:0045252) |
0.0 | 0.4 | GO:0008274 | gamma-tubulin large complex(GO:0000931) gamma-tubulin ring complex(GO:0008274) |
0.0 | 0.1 | GO:0043257 | laminin-8 complex(GO:0043257) |
0.0 | 0.2 | GO:1990425 | ryanodine receptor complex(GO:1990425) |
0.0 | 0.4 | GO:0000137 | Golgi cis cisterna(GO:0000137) |
0.0 | 0.8 | GO:0005892 | acetylcholine-gated channel complex(GO:0005892) |
0.0 | 0.2 | GO:0016013 | syntrophin complex(GO:0016013) |
0.0 | 0.6 | GO:0000813 | ESCRT I complex(GO:0000813) |
0.0 | 0.1 | GO:1903095 | microprocessor complex(GO:0070877) ribonuclease III complex(GO:1903095) |
0.0 | 0.3 | GO:0005832 | chaperonin-containing T-complex(GO:0005832) |
0.0 | 0.2 | GO:1990876 | cytoplasmic side of nuclear pore(GO:1990876) |
0.0 | 2.0 | GO:0000786 | nucleosome(GO:0000786) |
0.0 | 0.4 | GO:0016600 | flotillin complex(GO:0016600) |
0.0 | 0.2 | GO:0071012 | catalytic step 1 spliceosome(GO:0071012) |
0.0 | 0.2 | GO:0071203 | WASH complex(GO:0071203) |
0.0 | 0.8 | GO:0097038 | perinuclear endoplasmic reticulum(GO:0097038) |
0.0 | 0.4 | GO:0044666 | MLL3/4 complex(GO:0044666) |
0.0 | 0.2 | GO:0035692 | macrophage migration inhibitory factor receptor complex(GO:0035692) |
0.0 | 0.8 | GO:0097440 | apical dendrite(GO:0097440) |
0.0 | 0.5 | GO:0048188 | Set1C/COMPASS complex(GO:0048188) |
0.0 | 0.3 | GO:0033270 | paranode region of axon(GO:0033270) |
0.0 | 0.6 | GO:0046658 | anchored component of plasma membrane(GO:0046658) |
0.0 | 0.2 | GO:0035976 | AP1 complex(GO:0035976) |
0.0 | 0.4 | GO:0008278 | cohesin complex(GO:0008278) |
0.0 | 0.2 | GO:0072687 | meiotic spindle(GO:0072687) |
0.0 | 0.1 | GO:0036056 | filtration diaphragm(GO:0036056) slit diaphragm(GO:0036057) |
0.0 | 0.3 | GO:0097136 | Bcl-2 family protein complex(GO:0097136) |
0.0 | 1.2 | GO:0043034 | costamere(GO:0043034) |
0.0 | 0.2 | GO:0098554 | cytoplasmic side of endoplasmic reticulum membrane(GO:0098554) |
0.0 | 0.6 | GO:0034706 | sodium channel complex(GO:0034706) |
0.0 | 0.2 | GO:0034709 | methylosome(GO:0034709) |
0.0 | 0.3 | GO:0033179 | proton-transporting V-type ATPase, V0 domain(GO:0033179) |
0.0 | 3.2 | GO:0043202 | lysosomal lumen(GO:0043202) |
0.0 | 0.4 | GO:0005942 | phosphatidylinositol 3-kinase complex(GO:0005942) |
0.0 | 1.1 | GO:0016592 | mediator complex(GO:0016592) |
0.0 | 0.7 | GO:0035098 | ESC/E(Z) complex(GO:0035098) |
0.0 | 0.8 | GO:0016460 | myosin II complex(GO:0016460) |
0.0 | 0.2 | GO:0033256 | I-kappaB/NF-kappaB complex(GO:0033256) |
0.0 | 0.3 | GO:0005861 | troponin complex(GO:0005861) |
0.0 | 1.3 | GO:0005834 | heterotrimeric G-protein complex(GO:0005834) |
0.0 | 0.2 | GO:0042105 | alpha-beta T cell receptor complex(GO:0042105) |
0.0 | 1.0 | GO:0035371 | microtubule plus-end(GO:0035371) |
0.0 | 0.7 | GO:0042629 | mast cell granule(GO:0042629) |
0.0 | 0.6 | GO:0031307 | integral component of mitochondrial outer membrane(GO:0031307) |
0.0 | 2.4 | GO:0097517 | stress fiber(GO:0001725) contractile actin filament bundle(GO:0097517) |
0.0 | 0.4 | GO:0000783 | telomere cap complex(GO:0000782) nuclear telomere cap complex(GO:0000783) |
0.0 | 1.1 | GO:0045095 | keratin filament(GO:0045095) |
0.0 | 0.1 | GO:0034751 | aryl hydrocarbon receptor complex(GO:0034751) |
0.0 | 0.2 | GO:0005915 | zonula adherens(GO:0005915) |
0.0 | 0.1 | GO:0044294 | dendritic growth cone(GO:0044294) |
0.0 | 1.5 | GO:0034707 | chloride channel complex(GO:0034707) |
0.0 | 0.1 | GO:0035686 | sperm fibrous sheath(GO:0035686) |
0.0 | 1.5 | GO:0033116 | endoplasmic reticulum-Golgi intermediate compartment membrane(GO:0033116) |
0.0 | 0.5 | GO:0005689 | U12-type spliceosomal complex(GO:0005689) |
0.0 | 0.1 | GO:0001674 | female germ cell nucleus(GO:0001674) |
0.0 | 0.3 | GO:0031907 | peroxisomal matrix(GO:0005782) microbody lumen(GO:0031907) |
0.0 | 0.0 | GO:0071065 | alpha9-beta1 integrin-vascular cell adhesion molecule-1 complex(GO:0071065) |
0.0 | 0.4 | GO:0005682 | U5 snRNP(GO:0005682) |
0.0 | 0.3 | GO:0001931 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
0.0 | 0.1 | GO:0043625 | delta DNA polymerase complex(GO:0043625) |
0.0 | 0.3 | GO:0031229 | integral component of nuclear inner membrane(GO:0005639) intrinsic component of nuclear inner membrane(GO:0031229) |
0.0 | 0.2 | GO:0033643 | host cell part(GO:0033643) |
0.0 | 0.3 | GO:0071004 | U2-type prespliceosome(GO:0071004) |
0.0 | 0.2 | GO:0000815 | ESCRT III complex(GO:0000815) |
0.0 | 0.2 | GO:0034098 | VCP-NPL4-UFD1 AAA ATPase complex(GO:0034098) |
0.0 | 0.3 | GO:0008021 | synaptic vesicle(GO:0008021) |
0.0 | 0.2 | GO:0008290 | F-actin capping protein complex(GO:0008290) |
0.0 | 0.1 | GO:0030905 | retromer, tubulation complex(GO:0030905) |
0.0 | 0.2 | GO:0044300 | cerebellar mossy fiber(GO:0044300) |
0.0 | 0.1 | GO:0005945 | 6-phosphofructokinase complex(GO:0005945) |
0.0 | 1.0 | GO:0101003 | ficolin-1-rich granule membrane(GO:0101003) |
0.0 | 0.2 | GO:0031528 | microvillus membrane(GO:0031528) |
0.0 | 0.6 | GO:0002102 | podosome(GO:0002102) |
0.0 | 1.9 | GO:0032587 | ruffle membrane(GO:0032587) |
0.0 | 0.8 | GO:0098852 | lysosomal membrane(GO:0005765) lytic vacuole membrane(GO:0098852) |
0.0 | 0.3 | GO:0044232 | organelle membrane contact site(GO:0044232) |
0.0 | 0.6 | GO:0005905 | clathrin-coated pit(GO:0005905) |
0.0 | 0.1 | GO:0071818 | BAT3 complex(GO:0071818) ER membrane insertion complex(GO:0072379) |
0.0 | 0.1 | GO:0005774 | vacuolar membrane(GO:0005774) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.5 | 1.6 | GO:0033867 | Fas-activated serine/threonine kinase activity(GO:0033867) |
0.3 | 0.9 | GO:0034353 | RNA pyrophosphohydrolase activity(GO:0034353) |
0.3 | 0.8 | GO:0004821 | histidine-tRNA ligase activity(GO:0004821) |
0.2 | 0.2 | GO:0032395 | MHC class II receptor activity(GO:0032395) |
0.2 | 0.7 | GO:0015375 | glycine:sodium symporter activity(GO:0015375) |
0.2 | 0.6 | GO:0042356 | GDP-4-dehydro-D-rhamnose reductase activity(GO:0042356) GDP-L-fucose synthase activity(GO:0050577) |
0.2 | 0.6 | GO:0061714 | folic acid receptor activity(GO:0061714) |
0.2 | 0.8 | GO:0036134 | thromboxane-A synthase activity(GO:0004796) 12-hydroxyheptadecatrienoic acid synthase activity(GO:0036134) |
0.2 | 0.6 | GO:0045485 | omega-6 fatty acid desaturase activity(GO:0045485) |
0.2 | 0.8 | GO:0003974 | UDP-N-acetylglucosamine 4-epimerase activity(GO:0003974) UDP-glucose 4-epimerase activity(GO:0003978) |
0.2 | 0.9 | GO:0004910 | interleukin-1, Type II, blocking receptor activity(GO:0004910) |
0.2 | 0.5 | GO:0008048 | calcium sensitive guanylate cyclase activator activity(GO:0008048) |
0.2 | 0.7 | GO:0031849 | olfactory receptor binding(GO:0031849) |
0.2 | 2.8 | GO:0036374 | glutathione hydrolase activity(GO:0036374) |
0.1 | 1.7 | GO:0031419 | cobalamin binding(GO:0031419) |
0.1 | 1.0 | GO:0005157 | macrophage colony-stimulating factor receptor binding(GO:0005157) |
0.1 | 1.1 | GO:0097603 | temperature-gated ion channel activity(GO:0097603) |
0.1 | 0.4 | GO:0016534 | cyclin-dependent protein kinase 5 activator activity(GO:0016534) |
0.1 | 0.4 | GO:0015633 | zinc transporting ATPase activity(GO:0015633) |
0.1 | 1.0 | GO:0005534 | galactose binding(GO:0005534) |
0.1 | 1.0 | GO:0015186 | L-glutamine transmembrane transporter activity(GO:0015186) |
0.1 | 0.4 | GO:0038131 | neuregulin receptor activity(GO:0038131) |
0.1 | 0.4 | GO:0042007 | interleukin-18 binding(GO:0042007) |
0.1 | 0.6 | GO:0047756 | chondroitin 4-sulfotransferase activity(GO:0047756) |
0.1 | 1.2 | GO:0048495 | Roundabout binding(GO:0048495) |
0.1 | 0.4 | GO:0015068 | amidinotransferase activity(GO:0015067) glycine amidinotransferase activity(GO:0015068) |
0.1 | 0.3 | GO:0031177 | phosphopantetheine binding(GO:0031177) |
0.1 | 0.3 | GO:0036487 | nitric-oxide synthase inhibitor activity(GO:0036487) |
0.1 | 0.5 | GO:0043208 | glycosphingolipid binding(GO:0043208) |
0.1 | 0.4 | GO:0034602 | oxoglutarate dehydrogenase (NAD+) activity(GO:0034602) |
0.1 | 0.9 | GO:0070740 | tubulin-glutamic acid ligase activity(GO:0070740) |
0.1 | 0.7 | GO:0051022 | GDP-dissociation inhibitor binding(GO:0051021) Rho GDP-dissociation inhibitor binding(GO:0051022) |
0.1 | 0.6 | GO:0043183 | vascular endothelial growth factor receptor 1 binding(GO:0043183) |
0.1 | 1.8 | GO:0015232 | heme transporter activity(GO:0015232) |
0.1 | 0.8 | GO:0052794 | exo-alpha-(2->3)-sialidase activity(GO:0052794) exo-alpha-(2->6)-sialidase activity(GO:0052795) exo-alpha-(2->8)-sialidase activity(GO:0052796) |
0.1 | 0.7 | GO:0031962 | mineralocorticoid receptor binding(GO:0031962) |
0.1 | 0.4 | GO:0000404 | heteroduplex DNA loop binding(GO:0000404) |
0.1 | 2.1 | GO:0004143 | diacylglycerol kinase activity(GO:0004143) |
0.1 | 0.2 | GO:0005503 | all-trans retinal binding(GO:0005503) |
0.1 | 0.3 | GO:0098640 | integrin binding involved in cell-matrix adhesion(GO:0098640) |
0.1 | 0.6 | GO:0050119 | N-acetylglucosamine deacetylase activity(GO:0050119) |
0.1 | 0.1 | GO:0035241 | protein-arginine omega-N monomethyltransferase activity(GO:0035241) |
0.1 | 0.8 | GO:0047623 | AMP deaminase activity(GO:0003876) adenosine-phosphate deaminase activity(GO:0047623) |
0.1 | 0.8 | GO:0030368 | interleukin-17 receptor activity(GO:0030368) |
0.1 | 0.6 | GO:0034988 | Fc-gamma receptor I complex binding(GO:0034988) |
0.1 | 1.6 | GO:0031702 | type 1 angiotensin receptor binding(GO:0031702) |
0.1 | 0.4 | GO:0008798 | beta-aspartyl-peptidase activity(GO:0008798) |
0.1 | 0.2 | GO:0004024 | alcohol dehydrogenase activity, zinc-dependent(GO:0004024) |
0.1 | 0.3 | GO:0005046 | KDEL sequence binding(GO:0005046) |
0.1 | 0.7 | GO:0019237 | centromeric DNA binding(GO:0019237) |
0.1 | 0.4 | GO:0031726 | CCR1 chemokine receptor binding(GO:0031726) |
0.1 | 0.4 | GO:0008309 | double-stranded DNA exodeoxyribonuclease activity(GO:0008309) |
0.1 | 0.6 | GO:0004993 | G-protein coupled serotonin receptor activity(GO:0004993) amine binding(GO:0043176) serotonin binding(GO:0051378) |
0.1 | 0.5 | GO:0043237 | laminin-1 binding(GO:0043237) |
0.1 | 0.8 | GO:0017176 | phosphatidylinositol N-acetylglucosaminyltransferase activity(GO:0017176) |
0.1 | 0.3 | GO:0015180 | L-alanine transmembrane transporter activity(GO:0015180) alanine transmembrane transporter activity(GO:0022858) |
0.1 | 0.5 | GO:0010997 | anaphase-promoting complex binding(GO:0010997) |
0.1 | 1.1 | GO:0016176 | superoxide-generating NADPH oxidase activator activity(GO:0016176) |
0.1 | 0.6 | GO:0015272 | ATP-activated inward rectifier potassium channel activity(GO:0015272) |
0.1 | 0.2 | GO:0004657 | proline dehydrogenase activity(GO:0004657) |
0.1 | 0.2 | GO:0048248 | CXCR3 chemokine receptor binding(GO:0048248) |
0.1 | 0.2 | GO:0033981 | D-dopachrome decarboxylase activity(GO:0033981) |
0.1 | 0.5 | GO:1990599 | 3' overhang single-stranded DNA endodeoxyribonuclease activity(GO:1990599) |
0.1 | 0.2 | GO:0031694 | alpha-2A adrenergic receptor binding(GO:0031694) |
0.1 | 0.6 | GO:0004687 | myosin light chain kinase activity(GO:0004687) |
0.1 | 0.4 | GO:0004699 | calcium-independent protein kinase C activity(GO:0004699) |
0.1 | 0.5 | GO:0032810 | sterol response element binding(GO:0032810) |
0.1 | 0.3 | GO:0035662 | Toll-like receptor 4 binding(GO:0035662) |
0.1 | 0.5 | GO:0001025 | RNA polymerase III transcription factor binding(GO:0001025) |
0.1 | 0.3 | GO:0001591 | dopamine neurotransmitter receptor activity, coupled via Gi/Go(GO:0001591) |
0.1 | 0.4 | GO:0042289 | MHC class II protein binding(GO:0042289) |
0.1 | 0.3 | GO:0046935 | 1-phosphatidylinositol-3-kinase regulator activity(GO:0046935) |
0.1 | 0.4 | GO:0001165 | RNA polymerase I upstream control element sequence-specific DNA binding(GO:0001165) |
0.1 | 0.5 | GO:0003827 | alpha-1,3-mannosylglycoprotein 2-beta-N-acetylglucosaminyltransferase activity(GO:0003827) |
0.0 | 0.2 | GO:0004052 | arachidonate 12-lipoxygenase activity(GO:0004052) |
0.0 | 0.1 | GO:0004731 | purine-nucleoside phosphorylase activity(GO:0004731) |
0.0 | 0.1 | GO:0001640 | adenylate cyclase inhibiting G-protein coupled glutamate receptor activity(GO:0001640) G-protein coupled glutamate receptor activity(GO:0098988) |
0.0 | 0.2 | GO:0004449 | isocitrate dehydrogenase (NAD+) activity(GO:0004449) |
0.0 | 0.7 | GO:0004972 | NMDA glutamate receptor activity(GO:0004972) |
0.0 | 0.5 | GO:0004046 | aminoacylase activity(GO:0004046) |
0.0 | 0.6 | GO:0097016 | L27 domain binding(GO:0097016) |
0.0 | 0.3 | GO:0047288 | monosialoganglioside sialyltransferase activity(GO:0047288) |
0.0 | 0.4 | GO:0044323 | retinoic acid-responsive element binding(GO:0044323) |
0.0 | 0.5 | GO:0008440 | inositol-1,4,5-trisphosphate 3-kinase activity(GO:0008440) |
0.0 | 0.4 | GO:0036042 | long-chain fatty acyl-CoA binding(GO:0036042) |
0.0 | 0.8 | GO:0030957 | Tat protein binding(GO:0030957) |
0.0 | 0.4 | GO:0070097 | delta-catenin binding(GO:0070097) |
0.0 | 0.4 | GO:0005087 | Ran guanyl-nucleotide exchange factor activity(GO:0005087) |
0.0 | 1.0 | GO:0045294 | alpha-catenin binding(GO:0045294) |
0.0 | 0.4 | GO:0019826 | oxygen sensor activity(GO:0019826) |
0.0 | 0.8 | GO:0042809 | vitamin D receptor binding(GO:0042809) |
0.0 | 0.8 | GO:0022848 | acetylcholine-gated cation channel activity(GO:0022848) |
0.0 | 0.7 | GO:0004030 | aldehyde dehydrogenase [NAD(P)+] activity(GO:0004030) |
0.0 | 0.6 | GO:0022841 | potassium ion leak channel activity(GO:0022841) |
0.0 | 0.3 | GO:0047820 | D-glutamate cyclase activity(GO:0047820) |
0.0 | 1.5 | GO:0004653 | polypeptide N-acetylgalactosaminyltransferase activity(GO:0004653) |
0.0 | 0.9 | GO:0005068 | transmembrane receptor protein tyrosine kinase adaptor activity(GO:0005068) |
0.0 | 0.3 | GO:0000064 | L-ornithine transmembrane transporter activity(GO:0000064) |
0.0 | 0.5 | GO:1990380 | Lys48-specific deubiquitinase activity(GO:1990380) |
0.0 | 0.2 | GO:0016971 | flavin-linked sulfhydryl oxidase activity(GO:0016971) |
0.0 | 1.1 | GO:0008569 | ATP-dependent microtubule motor activity, minus-end-directed(GO:0008569) |
0.0 | 1.1 | GO:0016676 | cytochrome-c oxidase activity(GO:0004129) heme-copper terminal oxidase activity(GO:0015002) oxidoreductase activity, acting on a heme group of donors, oxygen as acceptor(GO:0016676) |
0.0 | 0.2 | GO:0034617 | nitric-oxide synthase activity(GO:0004517) tetrahydrobiopterin binding(GO:0034617) |
0.0 | 0.4 | GO:0035381 | extracellular ATP-gated cation channel activity(GO:0004931) ATP-gated ion channel activity(GO:0035381) |
0.0 | 0.2 | GO:0004447 | iodide peroxidase activity(GO:0004447) |
0.0 | 0.5 | GO:0047499 | calcium-independent phospholipase A2 activity(GO:0047499) |
0.0 | 1.1 | GO:0017166 | vinculin binding(GO:0017166) |
0.0 | 0.2 | GO:0005280 | hydrogen:amino acid symporter activity(GO:0005280) |
0.0 | 0.2 | GO:0031708 | endothelin B receptor binding(GO:0031708) |
0.0 | 0.2 | GO:0001849 | complement component C1q binding(GO:0001849) |
0.0 | 0.4 | GO:0045159 | myosin II binding(GO:0045159) |
0.0 | 0.4 | GO:0015379 | potassium:chloride symporter activity(GO:0015379) potassium ion symporter activity(GO:0022820) |
0.0 | 0.4 | GO:0051434 | BH3 domain binding(GO:0051434) |
0.0 | 0.7 | GO:0070016 | armadillo repeat domain binding(GO:0070016) |
0.0 | 0.1 | GO:0001133 | RNA polymerase II transcription factor activity, sequence-specific transcription regulatory region DNA binding(GO:0001133) |
0.0 | 0.1 | GO:0061629 | RNA polymerase II sequence-specific DNA binding transcription factor binding(GO:0061629) |
0.0 | 0.1 | GO:0004382 | guanosine-diphosphatase activity(GO:0004382) |
0.0 | 0.3 | GO:0008142 | oxysterol binding(GO:0008142) |
0.0 | 1.9 | GO:0070412 | R-SMAD binding(GO:0070412) |
0.0 | 0.9 | GO:0005095 | GTPase inhibitor activity(GO:0005095) |
0.0 | 0.7 | GO:0009931 | calcium-dependent protein serine/threonine kinase activity(GO:0009931) |
0.0 | 0.2 | GO:0048406 | nerve growth factor binding(GO:0048406) |
0.0 | 0.3 | GO:0008553 | hydrogen-exporting ATPase activity, phosphorylative mechanism(GO:0008553) |
0.0 | 0.4 | GO:0042731 | PH domain binding(GO:0042731) |
0.0 | 1.1 | GO:0000217 | DNA secondary structure binding(GO:0000217) |
0.0 | 0.7 | GO:0070006 | metalloaminopeptidase activity(GO:0070006) |
0.0 | 0.1 | GO:0001069 | regulatory region RNA binding(GO:0001069) |
0.0 | 0.2 | GO:0016286 | small conductance calcium-activated potassium channel activity(GO:0016286) |
0.0 | 0.3 | GO:0050786 | RAGE receptor binding(GO:0050786) |
0.0 | 0.1 | GO:0061599 | molybdopterin adenylyltransferase activity(GO:0061598) molybdopterin molybdotransferase activity(GO:0061599) |
0.0 | 0.1 | GO:0004461 | lactose synthase activity(GO:0004461) |
0.0 | 0.2 | GO:0005004 | GPI-linked ephrin receptor activity(GO:0005004) neurotrophin receptor activity(GO:0005030) |
0.0 | 0.2 | GO:0044020 | histone methyltransferase activity (H4-R3 specific)(GO:0044020) |
0.0 | 0.2 | GO:0030229 | very-low-density lipoprotein particle receptor activity(GO:0030229) |
0.0 | 0.4 | GO:0031995 | insulin-like growth factor II binding(GO:0031995) |
0.0 | 0.2 | GO:0003989 | acetyl-CoA carboxylase activity(GO:0003989) |
0.0 | 0.1 | GO:0008453 | alanine-glyoxylate transaminase activity(GO:0008453) |
0.0 | 1.4 | GO:0001205 | transcriptional activator activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001205) |
0.0 | 0.1 | GO:0004582 | dolichyl-phosphate beta-D-mannosyltransferase activity(GO:0004582) |
0.0 | 0.1 | GO:0004525 | ribonuclease III activity(GO:0004525) double-stranded RNA-specific ribonuclease activity(GO:0032296) |
0.0 | 0.7 | GO:0005523 | tropomyosin binding(GO:0005523) |
0.0 | 0.3 | GO:0031545 | peptidyl-proline 4-dioxygenase activity(GO:0031545) |
0.0 | 0.4 | GO:0016783 | sulfurtransferase activity(GO:0016783) |
0.0 | 0.6 | GO:0071949 | FAD binding(GO:0071949) |
0.0 | 0.5 | GO:0004017 | adenylate kinase activity(GO:0004017) |
0.0 | 0.6 | GO:0016702 | oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen(GO:0016702) |
0.0 | 0.4 | GO:0017034 | Rap guanyl-nucleotide exchange factor activity(GO:0017034) |
0.0 | 0.1 | GO:0017095 | heparan sulfate 6-O-sulfotransferase activity(GO:0017095) |
0.0 | 0.4 | GO:0048185 | activin binding(GO:0048185) |
0.0 | 0.1 | GO:0005019 | platelet-derived growth factor beta-receptor activity(GO:0005019) |
0.0 | 0.1 | GO:0004331 | 6-phosphofructo-2-kinase activity(GO:0003873) fructose-2,6-bisphosphate 2-phosphatase activity(GO:0004331) |
0.0 | 1.0 | GO:0004115 | 3',5'-cyclic-AMP phosphodiesterase activity(GO:0004115) |
0.0 | 0.5 | GO:0003857 | 3-hydroxyacyl-CoA dehydrogenase activity(GO:0003857) |
0.0 | 0.5 | GO:0008432 | JUN kinase binding(GO:0008432) |
0.0 | 0.4 | GO:0009982 | pseudouridine synthase activity(GO:0009982) |
0.0 | 0.3 | GO:0003964 | telomerase activity(GO:0003720) RNA-directed DNA polymerase activity(GO:0003964) |
0.0 | 0.1 | GO:0005251 | delayed rectifier potassium channel activity(GO:0005251) |
0.0 | 0.1 | GO:1990460 | leptin receptor binding(GO:1990460) |
0.0 | 0.2 | GO:0038187 | signaling pattern recognition receptor activity(GO:0008329) pattern recognition receptor activity(GO:0038187) |
0.0 | 0.0 | GO:0050659 | N-acetylgalactosamine 4-sulfate 6-O-sulfotransferase activity(GO:0050659) |
0.0 | 0.3 | GO:0004791 | thioredoxin-disulfide reductase activity(GO:0004791) |
0.0 | 0.5 | GO:0008253 | 5'-nucleotidase activity(GO:0008253) |
0.0 | 0.5 | GO:0003995 | acyl-CoA dehydrogenase activity(GO:0003995) |
0.0 | 0.1 | GO:0015562 | efflux transmembrane transporter activity(GO:0015562) |
0.0 | 0.1 | GO:0019956 | chemokine binding(GO:0019956) |
0.0 | 0.3 | GO:0008474 | palmitoyl-(protein) hydrolase activity(GO:0008474) palmitoyl hydrolase activity(GO:0098599) |
0.0 | 0.6 | GO:0001965 | G-protein alpha-subunit binding(GO:0001965) |
0.0 | 0.6 | GO:0051371 | muscle alpha-actinin binding(GO:0051371) |
0.0 | 0.2 | GO:0097157 | pre-mRNA intronic binding(GO:0097157) |
0.0 | 0.1 | GO:0070095 | fructose-6-phosphate binding(GO:0070095) |
0.0 | 0.3 | GO:0008526 | phosphatidylinositol transporter activity(GO:0008526) |
0.0 | 0.2 | GO:0001042 | RNA polymerase I core binding(GO:0001042) |
0.0 | 0.2 | GO:0004720 | protein-lysine 6-oxidase activity(GO:0004720) |
0.0 | 0.2 | GO:0004111 | creatine kinase activity(GO:0004111) |
0.0 | 0.2 | GO:0043047 | single-stranded telomeric DNA binding(GO:0043047) G-rich strand telomeric DNA binding(GO:0098505) |
0.0 | 0.1 | GO:0004514 | nicotinate-nucleotide diphosphorylase (carboxylating) activity(GO:0004514) |
0.0 | 0.2 | GO:0017150 | tRNA dihydrouridine synthase activity(GO:0017150) |
0.0 | 0.2 | GO:0005165 | neurotrophin receptor binding(GO:0005165) |
0.0 | 0.5 | GO:0042800 | histone methyltransferase activity (H3-K4 specific)(GO:0042800) |
0.0 | 0.1 | GO:0036435 | IkappaB kinase activity(GO:0008384) K48-linked polyubiquitin binding(GO:0036435) |
0.0 | 0.2 | GO:0004849 | uridine kinase activity(GO:0004849) |
0.0 | 0.7 | GO:0035326 | enhancer binding(GO:0035326) |
0.0 | 0.6 | GO:0098641 | cadherin binding involved in cell-cell adhesion(GO:0098641) |
0.0 | 4.7 | GO:0051015 | actin filament binding(GO:0051015) |
0.0 | 0.1 | GO:0008508 | bile acid:sodium symporter activity(GO:0008508) |
0.0 | 0.2 | GO:0019957 | C-C chemokine binding(GO:0019957) |
0.0 | 0.4 | GO:0030306 | ADP-ribosylation factor binding(GO:0030306) |
0.0 | 0.1 | GO:0004563 | beta-N-acetylhexosaminidase activity(GO:0004563) |
0.0 | 0.6 | GO:0008307 | structural constituent of muscle(GO:0008307) |
0.0 | 0.1 | GO:0051400 | BH domain binding(GO:0051400) |
0.0 | 0.2 | GO:0050291 | sphingosine N-acyltransferase activity(GO:0050291) |
0.0 | 1.5 | GO:0005201 | extracellular matrix structural constituent(GO:0005201) |
0.0 | 0.4 | GO:0008376 | acetylgalactosaminyltransferase activity(GO:0008376) |
0.0 | 0.5 | GO:0004385 | guanylate kinase activity(GO:0004385) |
0.0 | 0.2 | GO:0015093 | ferrous iron transmembrane transporter activity(GO:0015093) |
0.0 | 0.1 | GO:1990829 | C-rich single-stranded DNA binding(GO:1990829) |
0.0 | 0.2 | GO:1990226 | histone methyltransferase binding(GO:1990226) |
0.0 | 0.1 | GO:0008093 | cytoskeletal adaptor activity(GO:0008093) |
0.0 | 0.3 | GO:0010485 | H4 histone acetyltransferase activity(GO:0010485) |
0.0 | 2.1 | GO:0042826 | histone deacetylase binding(GO:0042826) |
0.0 | 0.1 | GO:0034714 | type III transforming growth factor beta receptor binding(GO:0034714) |
0.0 | 0.3 | GO:0005184 | neuropeptide hormone activity(GO:0005184) |
0.0 | 0.4 | GO:0005092 | GDP-dissociation inhibitor activity(GO:0005092) |
0.0 | 0.1 | GO:0005154 | epidermal growth factor receptor binding(GO:0005154) |
0.0 | 0.3 | GO:0008391 | arachidonic acid monooxygenase activity(GO:0008391) arachidonic acid epoxygenase activity(GO:0008392) |
0.0 | 0.5 | GO:0004033 | aldo-keto reductase (NADP) activity(GO:0004033) |
0.0 | 0.4 | GO:0015114 | phosphate ion transmembrane transporter activity(GO:0015114) |
0.0 | 0.1 | GO:0016206 | catechol O-methyltransferase activity(GO:0016206) |
0.0 | 0.1 | GO:0032036 | myosin heavy chain binding(GO:0032036) |
0.0 | 0.2 | GO:0016502 | G-protein coupled nucleotide receptor activity(GO:0001608) purinergic nucleotide receptor activity(GO:0001614) nucleotide receptor activity(GO:0016502) G-protein coupled purinergic nucleotide receptor activity(GO:0045028) |
0.0 | 0.6 | GO:0046875 | ephrin receptor binding(GO:0046875) |
0.0 | 0.1 | GO:0050544 | arachidonic acid binding(GO:0050544) |
0.0 | 0.1 | GO:0005047 | signal recognition particle binding(GO:0005047) |
0.0 | 0.2 | GO:0017110 | nucleoside-diphosphatase activity(GO:0017110) |
0.0 | 1.7 | GO:0005200 | structural constituent of cytoskeleton(GO:0005200) |
0.0 | 1.0 | GO:0004712 | protein serine/threonine/tyrosine kinase activity(GO:0004712) |
0.0 | 0.3 | GO:0070410 | co-SMAD binding(GO:0070410) |
0.0 | 0.5 | GO:0038191 | neuropilin binding(GO:0038191) |
0.0 | 0.1 | GO:0031996 | thioesterase binding(GO:0031996) |
0.0 | 0.3 | GO:0005248 | voltage-gated sodium channel activity(GO:0005248) voltage-gated ion channel activity involved in regulation of postsynaptic membrane potential(GO:1905030) |
0.0 | 0.4 | GO:0008139 | nuclear localization sequence binding(GO:0008139) |
0.0 | 0.1 | GO:0016015 | morphogen activity(GO:0016015) |
0.0 | 0.1 | GO:0052740 | 1-acyl-2-lysophosphatidylserine acylhydrolase activity(GO:0052740) |
0.0 | 2.4 | GO:0017124 | SH3 domain binding(GO:0017124) |
0.0 | 0.7 | GO:0048365 | Rac GTPase binding(GO:0048365) |
0.0 | 0.1 | GO:0016175 | superoxide-generating NADPH oxidase activity(GO:0016175) |
0.0 | 2.0 | GO:0005089 | Rho guanyl-nucleotide exchange factor activity(GO:0005089) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.0 | 1.6 | PID HDAC CLASSIII PATHWAY | Signaling events mediated by HDAC Class III |
0.0 | 0.6 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
0.0 | 0.2 | PID ERBB1 RECEPTOR PROXIMAL PATHWAY | EGF receptor (ErbB1) signaling pathway |
0.0 | 0.6 | PID VEGF VEGFR PATHWAY | VEGF and VEGFR signaling network |
0.0 | 2.1 | PID MAPK TRK PATHWAY | Trk receptor signaling mediated by the MAPK pathway |
0.0 | 1.7 | PID RXR VDR PATHWAY | RXR and RAR heterodimerization with other nuclear receptor |
0.0 | 1.7 | NABA COLLAGENS | Genes encoding collagen proteins |
0.0 | 1.9 | PID AVB3 OPN PATHWAY | Osteopontin-mediated events |
0.0 | 1.3 | SIG REGULATION OF THE ACTIN CYTOSKELETON BY RHO GTPASES | Genes related to regulation of the actin cytoskeleton |
0.0 | 0.8 | PID ARF 3PATHWAY | Arf1 pathway |
0.0 | 0.7 | SA B CELL RECEPTOR COMPLEXES | Antigen binding to B cell receptors activates protein tyrosine kinases, such as the Src family, which ultimate activate MAP kinases. |
0.0 | 0.3 | PID EPHB FWD PATHWAY | EPHB forward signaling |
0.0 | 0.6 | PID S1P S1P1 PATHWAY | S1P1 pathway |
0.0 | 0.4 | PID S1P S1P2 PATHWAY | S1P2 pathway |
0.0 | 0.1 | PID IL8 CXCR2 PATHWAY | IL8- and CXCR2-mediated signaling events |
0.0 | 1.9 | PID RAC1 PATHWAY | RAC1 signaling pathway |
0.0 | 1.2 | ST WNT BETA CATENIN PATHWAY | Wnt/beta-catenin Pathway |
0.0 | 1.8 | PID FAK PATHWAY | Signaling events mediated by focal adhesion kinase |
0.0 | 1.0 | PID ENDOTHELIN PATHWAY | Endothelins |
0.0 | 0.8 | PID ALK1 PATHWAY | ALK1 signaling events |
0.0 | 0.4 | PID PI3K PLC TRK PATHWAY | Trk receptor signaling mediated by PI3K and PLC-gamma |
0.0 | 0.9 | PID HIF2PATHWAY | HIF-2-alpha transcription factor network |
0.0 | 0.3 | PID TCR JNK PATHWAY | JNK signaling in the CD4+ TCR pathway |
0.0 | 0.7 | PID SMAD2 3PATHWAY | Regulation of cytoplasmic and nuclear SMAD2/3 signaling |
0.0 | 1.2 | PID FOXM1 PATHWAY | FOXM1 transcription factor network |
0.0 | 1.1 | PID CDC42 PATHWAY | CDC42 signaling events |
0.0 | 0.4 | PID ARF6 DOWNSTREAM PATHWAY | Arf6 downstream pathway |
0.0 | 0.6 | SIG PIP3 SIGNALING IN B LYMPHOCYTES | Genes related to PIP3 signaling in B lymphocytes |
0.0 | 0.7 | PID SHP2 PATHWAY | SHP2 signaling |
0.0 | 1.1 | PID AURORA B PATHWAY | Aurora B signaling |
0.0 | 0.1 | PID NEPHRIN NEPH1 PATHWAY | Nephrin/Neph1 signaling in the kidney podocyte |
0.0 | 1.1 | PID ERBB1 INTERNALIZATION PATHWAY | Internalization of ErbB1 |
0.0 | 0.6 | PID AVB3 INTEGRIN PATHWAY | Integrins in angiogenesis |
0.0 | 0.8 | PID AR TF PATHWAY | Regulation of Androgen receptor activity |
0.0 | 0.1 | PID ECADHERIN NASCENT AJ PATHWAY | E-cadherin signaling in the nascent adherens junction |
0.0 | 0.5 | SIG CD40PATHWAYMAP | Genes related to CD40 signaling |
0.0 | 0.2 | SIG PIP3 SIGNALING IN CARDIAC MYOCTES | Genes related to PIP3 signaling in cardiac myocytes |
0.0 | 0.5 | PID P38 MKK3 6PATHWAY | p38 MAPK signaling pathway |
0.0 | 0.6 | PID RAS PATHWAY | Regulation of Ras family activation |
0.0 | 0.5 | PID IL1 PATHWAY | IL1-mediated signaling events |
0.0 | 1.6 | PID MYC ACTIV PATHWAY | Validated targets of C-MYC transcriptional activation |
0.0 | 0.3 | ST P38 MAPK PATHWAY | p38 MAPK Pathway |
0.0 | 1.5 | PID PDGFRB PATHWAY | PDGFR-beta signaling pathway |
0.0 | 0.8 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
0.0 | 0.2 | PID EPO PATHWAY | EPO signaling pathway |
0.0 | 0.6 | PID HDAC CLASSII PATHWAY | Signaling events mediated by HDAC Class II |
0.0 | 1.1 | PID AR PATHWAY | Coregulation of Androgen receptor activity |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 0.4 | REACTOME BINDING AND ENTRY OF HIV VIRION | Genes involved in Binding and entry of HIV virion |
0.1 | 0.6 | REACTOME SEROTONIN RECEPTORS | Genes involved in Serotonin receptors |
0.1 | 0.8 | REACTOME HIGHLY CALCIUM PERMEABLE POSTSYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Highly calcium permeable postsynaptic nicotinic acetylcholine receptors |
0.0 | 1.6 | REACTOME DCC MEDIATED ATTRACTIVE SIGNALING | Genes involved in DCC mediated attractive signaling |
0.0 | 1.1 | REACTOME P38MAPK EVENTS | Genes involved in p38MAPK events |
0.0 | 1.1 | REACTOME ACTIVATION OF BH3 ONLY PROTEINS | Genes involved in Activation of BH3-only proteins |
0.0 | 0.9 | REACTOME PURINE SALVAGE | Genes involved in Purine salvage |
0.0 | 1.0 | REACTOME G BETA GAMMA SIGNALLING THROUGH PLC BETA | Genes involved in G beta:gamma signalling through PLC beta |
0.0 | 0.7 | REACTOME SIGNAL ATTENUATION | Genes involved in Signal attenuation |
0.0 | 0.9 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
0.0 | 1.2 | REACTOME SEMA4D INDUCED CELL MIGRATION AND GROWTH CONE COLLAPSE | Genes involved in Sema4D induced cell migration and growth-cone collapse |
0.0 | 0.6 | REACTOME ADENYLATE CYCLASE ACTIVATING PATHWAY | Genes involved in Adenylate cyclase activating pathway |
0.0 | 1.4 | REACTOME DOWNREGULATION OF TGF BETA RECEPTOR SIGNALING | Genes involved in Downregulation of TGF-beta receptor signaling |
0.0 | 1.9 | REACTOME SMOOTH MUSCLE CONTRACTION | Genes involved in Smooth Muscle Contraction |
0.0 | 0.6 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
0.0 | 1.2 | REACTOME LATENT INFECTION OF HOMO SAPIENS WITH MYCOBACTERIUM TUBERCULOSIS | Genes involved in Latent infection of Homo sapiens with Mycobacterium tuberculosis |
0.0 | 0.5 | REACTOME ACTIVATION OF RAC | Genes involved in Activation of Rac |
0.0 | 0.6 | REACTOME MTORC1 MEDIATED SIGNALLING | Genes involved in mTORC1-mediated signalling |
0.0 | 0.2 | REACTOME TGF BETA RECEPTOR SIGNALING ACTIVATES SMADS | Genes involved in TGF-beta receptor signaling activates SMADs |
0.0 | 0.1 | REACTOME GENERATION OF SECOND MESSENGER MOLECULES | Genes involved in Generation of second messenger molecules |
0.0 | 1.6 | REACTOME POST NMDA RECEPTOR ACTIVATION EVENTS | Genes involved in Post NMDA receptor activation events |
0.0 | 0.5 | REACTOME CYCLIN A B1 ASSOCIATED EVENTS DURING G2 M TRANSITION | Genes involved in Cyclin A/B1 associated events during G2/M transition |
0.0 | 0.9 | REACTOME NETRIN1 SIGNALING | Genes involved in Netrin-1 signaling |
0.0 | 0.8 | REACTOME FORMATION OF INCISION COMPLEX IN GG NER | Genes involved in Formation of incision complex in GG-NER |
0.0 | 0.4 | REACTOME NFKB IS ACTIVATED AND SIGNALS SURVIVAL | Genes involved in NF-kB is activated and signals survival |
0.0 | 1.1 | REACTOME EFFECTS OF PIP2 HYDROLYSIS | Genes involved in Effects of PIP2 hydrolysis |
0.0 | 0.9 | REACTOME POST CHAPERONIN TUBULIN FOLDING PATHWAY | Genes involved in Post-chaperonin tubulin folding pathway |
0.0 | 0.9 | REACTOME CASPASE MEDIATED CLEAVAGE OF CYTOSKELETAL PROTEINS | Genes involved in Caspase-mediated cleavage of cytoskeletal proteins |
0.0 | 0.6 | REACTOME MITOCHONDRIAL TRNA AMINOACYLATION | Genes involved in Mitochondrial tRNA aminoacylation |
0.0 | 0.9 | REACTOME SMAD2 SMAD3 SMAD4 HETEROTRIMER REGULATES TRANSCRIPTION | Genes involved in SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription |
0.0 | 1.0 | REACTOME KINESINS | Genes involved in Kinesins |
0.0 | 1.9 | REACTOME NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY | Genes involved in Nuclear Receptor transcription pathway |
0.0 | 0.6 | REACTOME CITRIC ACID CYCLE TCA CYCLE | Genes involved in Citric acid cycle (TCA cycle) |
0.0 | 0.6 | REACTOME AMINO ACID TRANSPORT ACROSS THE PLASMA MEMBRANE | Genes involved in Amino acid transport across the plasma membrane |
0.0 | 0.9 | REACTOME GLUTATHIONE CONJUGATION | Genes involved in Glutathione conjugation |
0.0 | 0.4 | REACTOME HYALURONAN UPTAKE AND DEGRADATION | Genes involved in Hyaluronan uptake and degradation |
0.0 | 0.5 | REACTOME ABCA TRANSPORTERS IN LIPID HOMEOSTASIS | Genes involved in ABCA transporters in lipid homeostasis |
0.0 | 0.7 | REACTOME REGULATORY RNA PATHWAYS | Genes involved in Regulatory RNA pathways |
0.0 | 2.3 | REACTOME TRANSCRIPTIONAL REGULATION OF WHITE ADIPOCYTE DIFFERENTIATION | Genes involved in Transcriptional Regulation of White Adipocyte Differentiation |
0.0 | 0.7 | REACTOME MRNA SPLICING MINOR PATHWAY | Genes involved in mRNA Splicing - Minor Pathway |
0.0 | 0.3 | REACTOME RNA POL I TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase I Transcription Termination |
0.0 | 0.7 | REACTOME HS GAG BIOSYNTHESIS | Genes involved in HS-GAG biosynthesis |
0.0 | 0.4 | REACTOME AMINE DERIVED HORMONES | Genes involved in Amine-derived hormones |
0.0 | 0.7 | REACTOME OXYGEN DEPENDENT PROLINE HYDROXYLATION OF HYPOXIA INDUCIBLE FACTOR ALPHA | Genes involved in Oxygen-dependent Proline Hydroxylation of Hypoxia-inducible Factor Alpha |
0.0 | 0.8 | REACTOME EGFR DOWNREGULATION | Genes involved in EGFR downregulation |
0.0 | 0.4 | REACTOME TRAFFICKING OF GLUR2 CONTAINING AMPA RECEPTORS | Genes involved in Trafficking of GluR2-containing AMPA receptors |
0.0 | 0.4 | REACTOME CRMPS IN SEMA3A SIGNALING | Genes involved in CRMPs in Sema3A signaling |
0.0 | 0.5 | REACTOME ALPHA LINOLENIC ACID ALA METABOLISM | Genes involved in alpha-linolenic acid (ALA) metabolism |
0.0 | 0.3 | REACTOME COMMON PATHWAY | Genes involved in Common Pathway |
0.0 | 1.0 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
0.0 | 0.4 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
0.0 | 0.6 | REACTOME STRIATED MUSCLE CONTRACTION | Genes involved in Striated Muscle Contraction |
0.0 | 0.4 | REACTOME REGULATION OF IFNA SIGNALING | Genes involved in Regulation of IFNA signaling |
0.0 | 1.0 | REACTOME NCAM1 INTERACTIONS | Genes involved in NCAM1 interactions |
0.0 | 0.2 | REACTOME CLASS C 3 METABOTROPIC GLUTAMATE PHEROMONE RECEPTORS | Genes involved in Class C/3 (Metabotropic glutamate/pheromone receptors) |
0.0 | 0.5 | REACTOME CHONDROITIN SULFATE BIOSYNTHESIS | Genes involved in Chondroitin sulfate biosynthesis |
0.0 | 0.9 | REACTOME GLYCOSPHINGOLIPID METABOLISM | Genes involved in Glycosphingolipid metabolism |
0.0 | 0.5 | REACTOME REGULATION OF SIGNALING BY CBL | Genes involved in Regulation of signaling by CBL |
0.0 | 0.5 | REACTOME ZINC TRANSPORTERS | Genes involved in Zinc transporters |
0.0 | 0.3 | REACTOME VITAMIN B5 PANTOTHENATE METABOLISM | Genes involved in Vitamin B5 (pantothenate) metabolism |
0.0 | 0.4 | REACTOME INFLAMMASOMES | Genes involved in Inflammasomes |
0.0 | 0.2 | REACTOME UNWINDING OF DNA | Genes involved in Unwinding of DNA |
0.0 | 0.3 | REACTOME NA CL DEPENDENT NEUROTRANSMITTER TRANSPORTERS | Genes involved in Na+/Cl- dependent neurotransmitter transporters |
0.0 | 0.3 | REACTOME SYNTHESIS OF PE | Genes involved in Synthesis of PE |
0.0 | 0.5 | REACTOME TIGHT JUNCTION INTERACTIONS | Genes involved in Tight junction interactions |
0.0 | 0.5 | REACTOME SYNTHESIS AND INTERCONVERSION OF NUCLEOTIDE DI AND TRIPHOSPHATES | Genes involved in Synthesis and interconversion of nucleotide di- and triphosphates |
0.0 | 0.2 | REACTOME GLUCAGON TYPE LIGAND RECEPTORS | Genes involved in Glucagon-type ligand receptors |
0.0 | 0.2 | REACTOME P2Y RECEPTORS | Genes involved in P2Y receptors |